<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">04494</article-id><article-id pub-id-type="doi">10.7554/eLife.04494</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-17705"><name><surname>MacDuff</surname><given-names>Donna A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18230"><name><surname>Reese</surname><given-names>Tiffany A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18231"><name><surname>Kimmey</surname><given-names>Jacqueline M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-13"/><xref ref-type="other" rid="par-14"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18232"><name><surname>Weiss</surname><given-names>Leslie A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18233"><name><surname>Song</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18234"><name><surname>Zhang</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18235"><name><surname>Kambal</surname><given-names>Amal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18236"><name><surname>Duan</surname><given-names>Erning</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18237"><name><surname>Carrero</surname><given-names>Javier A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18238"><name><surname>Boisson</surname><given-names>Bertrand</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18239"><name><surname>Laplantine</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18240"><name><surname>Israel</surname><given-names>Alain</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18241"><name><surname>Picard</surname><given-names>Capucine</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18242"><name><surname>Colonna</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18243"><name><surname>Edelson</surname><given-names>Brian T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18244"><name><surname>Sibley</surname><given-names>L David</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18245"><name><surname>Stallings</surname><given-names>Christina L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4925"><name><surname>Casanova</surname><given-names>Jean-Laurent</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18246"><name><surname>Iwai</surname><given-names>Kazuhiro</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-17326"><name><surname>Virgin</surname><given-names>Herbert W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Pathology and Immunology</institution>, <institution>Washington University School of Medicine</institution>, <addr-line><named-content content-type="city">St Louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Molecular Microbiology</institution>, <institution>Washington University School of Medicine</institution>, <addr-line><named-content content-type="city">St Louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution>Howard Hughes Medical Institute</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Laboratory of Molecular Signaling and Cell Activation</institution>, <institution>Institut Pasteur, Centre National de la Recherche Scientifique, Unité de Recherche Associée</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">St Giles Laboratory of Human Genetics of Infectious Disease</institution>, <institution>Rockefeller University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Study Center for Primary Immunodeficiency</institution>, <institution>Necker Hospital for Sick Children</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Laboratory of Human Genetics of Infectious Diseases, Necker Branch</institution>, <institution>Necker Hospital for Sick Children, Imagine Institute, INSERM UMR 1163</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Department of Molecular and Cellular Physiology, Graduate School of Medicine</institution>, <institution>Kyoto University</institution>, <addr-line><named-content content-type="city">Kyoto</named-content></addr-line>, <country>Japan</country></aff><aff id="aff9"><label>9</label><institution>Paris Descartes University</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff10"><label>10</label><institution content-type="dept">Pediatric Hematology-Immunology Unit</institution>, <institution>Necker Hospital for Sick Children</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Goff</surname><given-names>Stephen P</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>virgin@wustl.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>01</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>4</volume><elocation-id>e04494</elocation-id><history><date date-type="received"><day>24</day><month>08</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>© 2014, MacDuff et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>MacDuff et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-04494-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.04494.001</object-id><p>Variation in the presentation of hereditary immunodeficiencies may be explained by genetic or environmental factors. Patients with mutations in <italic>HOIL1</italic> (<italic>RBCK1</italic>) present with amylopectinosis-associated myopathy with or without hyper-inflammation and immunodeficiency. We report that barrier-raised HOIL-1-deficient mice exhibit amylopectin-like deposits in the myocardium but show minimal signs of hyper-inflammation. However, they show immunodeficiency upon acute infection with <italic>Listeria monocytogenes</italic>, <italic>Toxoplasma gondii</italic> or <italic>Citrobacter rodentium</italic>. Increased susceptibility to <italic>Listeria</italic> was due to HOIL-1 function in hematopoietic cells and macrophages in production of protective cytokines. In contrast, HOIL-1-deficient mice showed enhanced control of chronic <italic>Mycobacterium tuberculosis</italic> or murine γ-herpesvirus 68 (MHV68), and these infections conferred a hyper-inflammatory phenotype. Surprisingly, chronic infection with MHV68 complemented the immunodeficiency of HOIL-1, IL-6, Caspase-1 and Caspase-1;Caspase-11-deficient mice following <italic>Listeria</italic> infection. Thus chronic herpesvirus infection generates signs of auto-inflammation and complements genetic immunodeficiency in mutant mice, highlighting the importance of accounting for the virome in genotype-phenotype studies.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.001">http://dx.doi.org/10.7554/eLife.04494.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.04494.002</object-id><title>eLife digest</title><p>The immune system protects an individual from invading bacteria, viruses and parasites, as well as malfunctioning or cancerous host cells. However, some people inherit genetic defects that cause part of the immune system to be missing or to not work properly. This is called a genetic immunodeficiency, and puts individuals at a higher risk of infection and disease.</p><p>The symptoms of immunodeficiencies can vary substantially between individuals, even when they have defects in the same gene. For example, only some of the individuals who have defects in both of their copies of a gene called <italic>HOIL-1</italic>—which has been linked to several roles in the body's immune response—are reported to suffer from an altered susceptibility to bacterial infections and chronic (persistent) inflammation. Gaining a clear understanding of the possible factors that influence such variations in the symptoms of genetic immune deficiencies could help to speed up their diagnosis, as well as helping to develop more effective treatments.</p><p>MacDuff et al. studied mice that had mutations in both copies of the mouse equivalent of the <italic>HOIL-1</italic> gene. These mice, when raised in a clean barrier facility that reduces their exposure to viruses, were severely immunodeficient and died when infected by certain bacteria and parasites, including <italic>Listeria monocytogenes.</italic> However, they were able to tolerate infections with a herpesvirus or the bacterium that causes tuberculosis. The immunodeficiency to <italic>L. monocytogenes</italic> was linked to problems producing protective molecules called cytokines, which form a crucial part of the immune response. Unexpectedly, MacDuff et al. found that a chronic herpesvirus infection substantially protected these very immunodeficient animals from infection with <italic>Listeria monocytogenes</italic>, and the mice were able to efficiently produce protective cytokines.</p><p>Mice with two other distinct genetic deficiencies that affect their immune system were also better able to survive otherwise lethal bacterial infections if they had a long-term herpesvirus infection. Macduff et al. suggest that the chronic herpesvirus infection stimulates the immune system, and so allows it to compensate for the lack of cytokine production associated with various immunodeficiencies, including those caused by mutations in the <italic>HOIL-1</italic> gene. This suggests that the presence of viruses or other long-term infections may be responsible for some of the variability seen in the symptoms of different individuals with the same genetic immunodeficiency. This is an important concept since essentially all humans have life-long chronic infections from various herpesviruses, as well as other viruses that form the human virome.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.002">http://dx.doi.org/10.7554/eLife.04494.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>Listeria monocytogenes</kwd><kwd>murine gamma-herpesvirus 68</kwd><kwd>NF-kappaB</kwd><kwd>linear ubiquitination</kwd><kwd>immunodeficiency</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001063</institution-id><institution>Crohn's and Colitis Foundation of America</institution></institution-wrap></funding-source><award-id>Genetics Initiative grant 274415</award-id><principal-award-recipient><name><surname>Virgin</surname><given-names>Herbert W</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000898</institution-id><institution>Broad Foundation</institution></institution-wrap></funding-source><award-id>IBD-0357</award-id><principal-award-recipient><name><surname>Virgin</surname><given-names>Herbert W</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U19 AI109725</award-id><principal-award-recipient><name><surname>Virgin</surname><given-names>Herbert W</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000861</institution-id><institution>Burroughs Wellcome Fund</institution></institution-wrap></funding-source><award-id>Career Award for Medical Scientists</award-id><principal-award-recipient><name><surname>Edelson</surname><given-names>Brian T</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000912</institution-id><institution>March of Dimes Foundation</institution></institution-wrap></funding-source><award-id>Basil O'Conner Starter Scholar Research Award</award-id><principal-award-recipient><name><surname>Edelson</surname><given-names>Brian T</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Edward Mallinckrodt Jr Foundation</institution></institution-wrap></funding-source><award-id>Private Grant</award-id><principal-award-recipient><name><surname>Edelson</surname><given-names>Brian T</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI084887</award-id><principal-award-recipient><name><surname>Virgin</surname><given-names>Herbert W</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>5P01 AI061093</award-id><principal-award-recipient><name><surname>Casanova</surname><given-names>Jean-Laurent</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000097</institution-id><institution>National Center for Research Resources</institution></institution-wrap></funding-source><award-id>8UL1TR000043</award-id><principal-award-recipient><name><surname>Casanova</surname><given-names>Jean-Laurent</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AI036629</award-id><principal-award-recipient><name><surname>Sibley</surname><given-names>L David</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AI062832</award-id><principal-award-recipient><name><surname>Carrero</surname><given-names>Javier A</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000997</institution-id><institution>Arnold and Mabel Beckman Foundation</institution></institution-wrap></funding-source><award-id>Beckman Young Investigator Award</award-id><principal-award-recipient><name><surname>Stallings</surname><given-names>Christina L</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE-1143954</award-id><principal-award-recipient><name><surname>Kimmey</surname><given-names>Jacqueline M</given-names></name></principal-award-recipient></award-group><award-group id="par-14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM007067</award-id><principal-award-recipient><name><surname>Kimmey</surname><given-names>Jacqueline M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>HOIL-1 deficiency in mice results in a severe immunodeficiency that is effectively complemented by chronic infection with a murine gamma-herpesvirus.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>HOIL-1 (encoded by the <italic>RBCK1</italic> gene), HOIP (RNF31) and SHARPIN form the linear ubiquitin chain assembly complex (LUBAC), which linearly ubiquitinates receptor signaling complex components such as NEMO to enhance NF-κB activation after engagement of immune receptors including TNF-R1, IL-1R, CD40, TLRs and NOD2 (<xref ref-type="bibr" rid="bib32">Tokunaga et al., 2011</xref>; <xref ref-type="bibr" rid="bib34">Tokunaga et al., 2009</xref>; <xref ref-type="bibr" rid="bib14">Ikeda et al., 2011</xref>; <xref ref-type="bibr" rid="bib8">Gerlach et al., 2011</xref>; <xref ref-type="bibr" rid="bib9">Haas et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Zak et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Hostager et al., 2011</xref>; <xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>; <xref ref-type="bibr" rid="bib6">Damgaard et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Tian et al., 2007</xref>). Recently, HOIL-1/LUBAC was also shown to be important for activation of the NLRP3/ASC inflammasome in macrophages via linear ubiquitination of ASC (<xref ref-type="bibr" rid="bib22">Rodgers et al., 2014</xref>). These data suggest that HOIL-1 plays multiple roles in inflammation and infection. In mice, SHARPIN deficiency results in auto-inflammation involving multiple organs including the liver, esophagus, lung and, most noticeably, chronic proliferative dermatitis of the skin (<xref ref-type="bibr" rid="bib27">Seymour et al., 2007</xref>). The development and organization of secondary lymphoid organs and antibody isotype switching are also impaired in these mice (<xref ref-type="bibr" rid="bib11">HogenEsch et al., 1999</xref>). Loss of HOIP catalytic activity in B cells results in the impaired development of B1 B cells and antibody responses to antigen (<xref ref-type="bibr" rid="bib25">Sasaki et al., 2013</xref>). However, HOIL-1-deficient mice have not been analyzed extensively to date.</p><p>Sixteen patients with bi-allelic mutations in the gene encoding HOIL-1 have been reported (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Nilsson et al., 2013</xref>; <xref ref-type="bibr" rid="bib41">Wang et al., 2013</xref>). Three patients exhibited cardiomyopathy, amylopectinosis, hyper-inflammation and mild immunodeficiency associated with an increased frequency of bacterial infections, whereas other patients presented with amylopectinosis and myopathy alone (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The role of HOIL-1 in inflammation and immunity to infection in vivo is, therefore, uncertain.</p><p>Although there are multiple possible explanations for the variable clinical presentations of the reported patients including hypomorphic expression of HOIL-1 or effects of mutations on protein function, another possibility was that environmental factors alter the clinical presentation of HOIL-1 deficiency. In this study we define the function of HOIL-1 in murine immunity to infection and explore the potential role of the virome in determining HOIL-1 deficiency-associated phenotypes.</p><p>The bacterial microbiome and the virome regulate inflammation and immunity (<xref ref-type="bibr" rid="bib38">Virgin, 2014</xref>; <xref ref-type="bibr" rid="bib40">Virgin et al., 2009</xref>; <xref ref-type="bibr" rid="bib3">Belkaid and Hand, 2014</xref>). Within the virome, herpesviruses persistently infect most humans, and exert significant effects on innate immunity in mice during experimental chronic infection, including increasing resistance to tumors and a range of pathogens (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>; <xref ref-type="bibr" rid="bib44">White et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Yager et al., 2009</xref>; <xref ref-type="bibr" rid="bib19">Nguyen et al., 2008</xref>; <xref ref-type="bibr" rid="bib10">Haque et al., 2004</xref>). However, the potential effects of chronic infection on the phenotypic manifestations of immune deficiencies have not been considered.</p><p>In this study, we show that chronic herpesvirus infection can alter the presentation of several genetic immunodeficiencies in mice. We first found that, in naïve mice, HOIL-1 is essential during infection with <italic>Listeria monocytogenes</italic>, <italic>Toxoplasma gondii</italic> and <italic>Citrobacter rodentium</italic> and for efficient induction of pro-inflammatory cytokines that are known to be essential for resistance to lethal infection by hematopoietic cells during <italic>Listeria</italic> infection. In contrast, HOIL-1 knock-out (KO) mice, with null mutations in the <italic>Rbck1</italic> gene that encodes HOIL-1, were resistant to infection with murine γ-herpesvirus 68 (MHV68) and <italic>Mycobacterium tuberculosis</italic>. Although HOIL-1 KO mice raised in a barrier facility did not display signs of auto-inflammation, chronic infection with MHV68 or <italic>M. tuberculosis</italic> resulted in elevated inflammatory cytokines circulating in the serum, similar to that observed in some patients with mutations in <italic>RBCK1</italic> (<italic>HOIL1</italic>). Interestingly, latent infection with MHV68 rescued HOIL-1 deficient mice from lethality during <italic>Listeria</italic> infection and induced high levels of the protective cytokine, interferon-gamma (IFNγ). MHV68 latency also protected IL-6, Caspase-1 and Caspase-1;Caspase-11 deficient mice from <italic>Listeria</italic>-induced lethality, indicating that the ability of latent infection to complement a genetic immunodeficiency is not restricted to mutation of <italic>Hoil-1</italic>. These data indicate that chronic infections can modify the clinical presentations of genetic variations, thereby opening a new avenue for the analysis and interpretation of human genotype-phenotype association studies. We speculate that the protective effect of chronic herpesvirus infection is due to the stimulation of the function of the innate immune system in a manner that compensates for deficient early cytokine responses associated with multiple immunodeficiencies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>HOIL-1 is essential during acute infection with <italic>Listeria monocytogenes</italic>, <italic>Citrobacter rodentium</italic> and <italic>Toxoplasma gondii</italic></title><p>HOIL-1 KO mice (<xref ref-type="bibr" rid="bib34">Tokunaga et al., 2009</xref>) were born at Mendelian ratios and, in contrast to SHARPIN-deficient mice, failed to develop TNFα-driven inflammatory skin disease (<xref ref-type="bibr" rid="bib14">Ikeda et al., 2011</xref>; <xref ref-type="bibr" rid="bib8">Gerlach et al., 2011</xref>; <xref ref-type="bibr" rid="bib32">Tokunaga et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Tokunaga and Iwai, 2012</xref>) and exhibited normal histology of lymphoid organs, liver, lung, and kidney, and the presence of Peyer's patches along the small intestine (not shown). Aged HOIL-1 KO mice exhibited deposits of material that stained with periodic acid-Schiff reagent and was resistant to digestion with diastase, similar to the amylopectin-like material observed in humans with HOIL-1 deficiency (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>) (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>). Importantly, these barrier-raised mice showed minimal signs of baseline hyper-inflammation. In this regard, HOIL-1 KO mice exhibited normal numbers of lymphoid and myeloid cells in the spleen and thymus, normal complete blood counts (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A,B,D</xref>), and no detectable increase of tumor necrosis factor alpha (TNFα) or interleukin 6 (IL-6) in serum (discussed below). However, in the peritoneum, HOIL-1 KO mice contained about twofold more B cells, T cells and resident macrophages without changes in other cell types (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). Expression of neighboring genes, <italic>Trib3</italic> and <italic>Tbc1d20</italic>, was unaffected by disruption of the <italic>Rbck1</italic> (<italic>Hoil1</italic>) gene (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>).</p><p>To determine the requirement for HOIL-1 during the immune response to infection in vivo, we challenged HOIL-1 KO mice with a number of different pathogens. Strikingly, HOIL-1 KO mice were highly susceptible to even low dose infection with the facultative gram-positive intracellular bacterium, <italic>Listeria monocytogenes</italic> (<italic>Listeria</italic>), with 80%, 80% and 50% of mice succumbing to infection within 10 days of intraperitoneal (i.p.) inoculation with 10<sup>5</sup>, 10<sup>4</sup> and 10<sup>3</sup> CFU, respectively (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Although bacterial burdens in the spleens and livers of control and HOIL-1 KO mice were similar 1 and 3 days post-infection with 10<sup>5</sup> CFU, bacterial CFUs were elevated in HOIL-1 KO mice by 6 days post-infection, indicating that HOIL-1 KO mice were unable to control and clear the bacteria (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Further, these mutant mice developed large inflammatory lesions in the liver, elevated liver enzymes in the serum, and widespread tissue destruction in the spleen (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>, not shown).<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.04494.006</object-id><label>Figure 1.</label><caption><title>HOIL-1 KO mice are highly susceptible to acute infection with <italic>Listeria monocytogenes</italic>, <italic>Toxoplasma gondii</italic> and <italic>Citrobacter rodentium</italic>.</title><p>(<bold>A</bold>) Survival of control (blue circles) and HOIL-1 KO (red squares) mice following i.p. inoculation with 10<sup>5</sup> (left panel; control <italic>n</italic> = 35, HOIL-1 KO <italic>n</italic> = 19), 10<sup>4</sup> (middle panel; control <italic>n</italic> = 15, HOIL-1 KO <italic>n</italic> = 15) or 10<sup>3</sup> (right panel; control <italic>n</italic> = 15, HOIL-1 KO <italic>n</italic> = 15) CFU <italic>Listeria</italic> strain EGD. (<bold>B</bold>) <italic>Listeria</italic> CFU in spleen and liver from control (blue circles) and HOIL-1 KO (red squares) mice infected with 10<sup>5</sup> CFU i.p. for 1 day (left panel), 3 days (middle panel) or 6 days (right panel). Each symbol represents an individual mouse and the mean log<sub>10</sub> CFU is indicated. The dashed line indicates the limit of detection. (<bold>C</bold>) Survival of control (blue circles) and HOIL-1 KO (red squares) mice following inoculation with 5000 (left panel; control <italic>n</italic> = 17, HOIL-1 KO <italic>n</italic> = 5) or 100 (middle panel; control <italic>n</italic> = 10, HOIL-1 KO <italic>n</italic> = 10) tachyzoites <italic>T. gondii</italic> strain Pru-luc. (<bold>D</bold>) Log<sub>10</sub> total flux (luciferase activity; photons per second) as a measure of parasite burden 8 days post-infection with 100 tachyzoites. Each symbol represents an individual mouse and the mean log<sub>10</sub> is indicated. (<bold>E</bold>,<bold>F</bold>) Survival (<bold>E</bold>) and weight (<bold>F</bold>) of control (blue circles) and HOIL-1 KO (red squares) mice following oral gavage with 2 × 10<sup>9</sup> CFU <italic>C. rodentium</italic>. n = 20/group for survival and n = 10/group for weight. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Statistical analyses were performed using logrank Mantel–Cox test (<bold>A</bold>, <bold>C</bold> and <bold>E</bold>), Mann–Whitney test (<bold>B</bold>), or <italic>t</italic>-test (<bold>D</bold>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.006">http://dx.doi.org/10.7554/eLife.04494.006</ext-link></p></caption><graphic xlink:href="elife-04494-fig1-v1"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.007</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Comparison of <italic>RBCK1/HOIL1</italic> alleles from <italic>RBCK1/HOIL1</italic>-mutant patients.</title><p>Npl4 zinc finger ubiquitin binding domain, RING; really interesting new gene E3 ligase domain, IBR; Inbetween-RING domain. <italic>HOIL1L/RBCK1</italic> isoform 2 (reference sequences NM_031229.2/NP_112506.2) was used for annotation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.007">http://dx.doi.org/10.7554/eLife.04494.007</ext-link></p></caption><graphic xlink:href="elife-04494-fig1-figsupp1-v1"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.008</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Myocardium from aged HOIL-1 KO mice contains amylopectin-like deposits.</title><p>Representative PAS (top), PAS plus diastase digestion (middle) and H&amp;E-stained sections of myocardium from 18 month-old HOIL-1 KO (right) and control (left) mice. The scale bar (inset) represents 100 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.008">http://dx.doi.org/10.7554/eLife.04494.008</ext-link></p></caption><graphic xlink:href="elife-04494-fig1-figsupp2-v1"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.009</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Analysis of hematopoietic cell populations from naïve HOIL-1 KO mice.</title><p>(<bold>A</bold>–<bold>C</bold>) Flow cytometric analysis of cell populations in the spleen (<bold>A</bold>), thymus (<bold>B</bold>) and peritoneum (<bold>C</bold>) of HOIL-1 KO (red squares) and control (blue circles) mice. DP; CD4, CD8 double-positive. (<bold>D</bold>) Complete blood counts from HOIL-1 KO (red squares) and control (blue circles) mice. WBC, white blood cells, ×10<sup>3</sup>/mm<sup>3</sup>, RBC, red blood cells, ×10<sup>6</sup>/mm<sup>3</sup>; HGB, hemoglobin, g/dl; HCT, hematocrit, %; MCV, mean corpuscular volume, µm<sup>3</sup>; MCH, mean corpuscular hemoglobin, pg; MCHC, mean corpuscular hemoglobin concentration, %; Seg Neu, segmented neutrophils, %; Lymphos, lymphocytes, %, Monos, monocytes, %. Eosinophils, basophils or band neutrophils were not detected. Each symbol represents an individual mouse and the mean is indicated.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.009">http://dx.doi.org/10.7554/eLife.04494.009</ext-link></p></caption><graphic xlink:href="elife-04494-fig1-figsupp3-v1"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.010</object-id><label>Figure 1—figure supplement 4.</label><caption><title><italic>Hoil1/Rbck1</italic> and neighboring gene (<italic>Trib3</italic> and <italic>Tbc1d20</italic>) transcript expression in control and HOIL-1 KO bone marrow derived macrophages.</title><p>Data represent the mean ± SEM from cells derived from four pairs of mice each analyzed in triplicate. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Statistical analyses were performed using <italic>t</italic>-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.010">http://dx.doi.org/10.7554/eLife.04494.010</ext-link></p></caption><graphic xlink:href="elife-04494-fig1-figsupp4-v1"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.011</object-id><label>Figure 1—figure supplement 5.</label><caption><title>Pathology of HOIL-1 KO mice during <italic>Listeria</italic> infection.</title><p>Alanine aminotransferase (ATL; left panel) and aspartate aminotransferase (AST; right panel) levels in serum from control (blue circles) and HOIL-1 KO (red squares) mice 6 days after infection with 10<sup>5</sup> CFU <italic>Listeria</italic>. Each symbol represents an individual mouse and the mean is indicated. *p ≤ 0.05, **p ≤ 0.01; <italic>t</italic>-test with Welch's correction.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.011">http://dx.doi.org/10.7554/eLife.04494.011</ext-link></p></caption><graphic xlink:href="elife-04494-fig1-figsupp5-v1"/></fig></fig-group></p><p>HOIL-1 KO mice were also highly susceptible to infection with a relatively avirulent type II strain of the intracellular apicomplexan parasite <italic>Toxoplasma gondii</italic> (<italic>T. gondii</italic>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Despite infection with 5000 parasites resulting in lethality in only 20% of control mice, 100 parasites was sufficient to induce lethality in 100% of HOIL-1 KO mice. Quantification of parasite-encoded luciferase expression in vivo revealed that HOIL-1 KO mice failed to control <italic>T. gondii</italic> replication by 8 days post-infection (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). HOIL-1 KO mice also succumbed to infection with the enteric gram-negative pathogen <italic>Citrobacter rodentium</italic>, whereas control mice were highly resistant (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>). These data indicated that loss of HOIL-1 expression confers profound immunodeficiency in barrier-raised mice.</p></sec><sec id="s2-2"><title>HOIL-1 is essential in bone marrow-derived innate immune cells during acute <italic>Listeria</italic> infection</title><p>To define the role of HOIL-1 in immunity, we examined the response to <italic>Listeria</italic> in more detail. One patient with HOIL-1-associated immunodeficiency showed signs of recovery from hyper-inflammation after hematopoietic stem cell transplantation (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>). In mice, reciprocal bone marrow transplantation revealed that expression of HOIL-1 in radiation-sensitive hematopoietic cells was critical for resistance to <italic>Listeria</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). We noted that control mice that received control bone marrow were slightly more susceptible to infection than non-irradiated control mice (compare with <xref ref-type="fig" rid="fig1">Figure 1A</xref>), suggesting that reconstitution does not fully restore the immune system of a lethally irradiated mouse to that of a non-irradiated animal. Despite this caveat, irradiated wild-type control mice that received HOIL-1 KO bone marrow and were challenged with 10<sup>5</sup> <italic>Listeria</italic> 8 weeks later succumbed to infection at the same rate as HOIL-1 KO mice that had received HOIL-1 KO bone marrow. HOIL-1 KO mice that received control bone marrow had an increased survival rate, but still succumbed more readily than control mice that received control bone marrow. These data indicate that, while HOIL-1 expression is essential in bone marrow-derived cells, HOIL-1 may also play a role in radiation resistant cells during <italic>Listeria</italic> infection.<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.04494.012</object-id><label>Figure 2.</label><caption><title>HOIL-1 is required in an innate immune cell compartment during <italic>Listeria</italic> infection.</title><p>(<bold>A</bold>) Survival of control and HOIL-1 KO reciprocal bone marrow chimeric mice following infection with 10<sup>5</sup> CFU <italic>Listeria</italic>. *p ≤ 0.0083; logrank Mantel–Cox test corrected for multiple comparisons. (<bold>B</bold>) Survival of RAG1 KO HOIL-1 WT (blue circles; <italic>n</italic> = 12) and RAG1 KO HOIL-1 KO (red squares; <italic>n=</italic>11) mice following infection with 10<sup>4</sup> CFU <italic>Listeria</italic>. (<bold>C</bold>) <italic>Listeria</italic> CFU in spleen and liver from RAG1 KO HOIL-1 WT (blue circles) and RAG1 KO HOIL-1 KO (red squares) mice infected with 10<sup>4</sup> CFU for 3 days. Each symbol represents an individual mouse and the mean log<sub>10</sub> is indicated. For <bold>B</bold> and <bold>C</bold>, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001; logrank Mantel–Cox test and Mann–Whitney test, respectively.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.012">http://dx.doi.org/10.7554/eLife.04494.012</ext-link></p></caption><graphic xlink:href="elife-04494-fig2-v1"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.013</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Confirmation of hematopoietic reconstitution of bone marrow chimeric mice.</title><p>Percent <italic>Hoil1/Rbck1</italic><sup><italic>+/+</italic></sup> (<italic>Hoil1/Rbck1</italic> intron 7; top panel) and percent <italic>Hoil1/Rbck1</italic><sup><italic>−/−</italic></sup> (neomycin-resistance cassette; bottom panel) genomic DNA (gDNA) in peripheral blood from control and HOIL-1 KO reciprocal bone marrow chimeric mice determined by qPCR.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.013">http://dx.doi.org/10.7554/eLife.04494.013</ext-link></p></caption><graphic xlink:href="elife-04494-fig2-figsupp1-v1"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.014</object-id><label>Figure 2—figure supplement 2.</label><caption><title>HOIL-1 KO mice are capable of generating an adaptive immune response to <italic>Listeria</italic>.</title><p><italic>Listeria</italic> titers in spleen and liver of naïve (circles) or pre-immunized (10<sup>3</sup> CFU for 28 days, squares) control (blue symbols) and HOIL-1 KO (red symbols) mice challenged with 10<sup>6</sup> CFU <italic>Listeria</italic> for 3 days. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Statistical analyses were performed using two-way ANOVA with Holm-Sidak's multiple comparison test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.014">http://dx.doi.org/10.7554/eLife.04494.014</ext-link></p></caption><graphic xlink:href="elife-04494-fig2-figsupp2-v1"/></fig></fig-group></p><p>To determine whether HOIL-1 deficiency resulted in a defect in innate or adaptive immunity, we bred the HOIL-1 KO mice onto a RAG1-deficient background. T and B cell-deficient RAG1 HOIL-1 double KO mice succumbed to infection significantly faster than RAG1 KO mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), and exhibited elevated bacterial burden in the spleen and liver 3 days post-infection (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), indicating that HOIL-1 plays an essential role in innate immunity during <italic>Listeria</italic> infection. Indeed, HOIL-1-deficient mice succumbed to infection at the same rate regardless of the presence or absence of the adaptive immune system (compare <xref ref-type="fig" rid="fig1 fig2">Figures 1A and 2B</xref>). Further, HOIL-1 KO mice immunized with a low dose of <italic>Listeria</italic> were capable of mounting a protective adaptive response to a high dose secondary challenge with <italic>Listeria</italic> 28 days later (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). We noted that 1000 CFU administered i.p. was a borderline dose required to successfully immunize control mice in our experiments, despite being sufficient to induce lethality in 50% of HOIL-1 KO mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Together, these data do not rule out a role for HOIL-1 in adaptive immunity, but show that HOIL-1 plays a major role in hematopoietic cells to foster innate immunity to <italic>Listeria</italic> infection.</p></sec><sec id="s2-3"><title>HOIL-1 is required for efficient production of pro-inflammatory cytokines by macrophages in response to <italic>Listeria</italic> infection</title><p>Innate immunity to <italic>Listeria</italic> in mice depends on tissue-resident macrophages and CD8α<sup>+</sup> dendritic cells responding to <italic>Listeria</italic> infection by secreting pro-inflammatory cytokines including TNFα, IL-12, and IL-6. These cytokines are each well recognized to be essential for survival after <italic>Listeria</italic> infection (<xref ref-type="bibr" rid="bib36">Unanue, 1997</xref>; <xref ref-type="bibr" rid="bib45">Williams et al., 2012</xref>) through their role in coordinating activation of NK cells, NKT cell and T cells to produce IFNγ required for the bactericidal activity of phagocytic cells. Therefore, to further define a role for HOIL-1 in the innate immune system, we determined whether HOIL-1 KO bone marrow-derived macrophages (macrophages herein) produced cytokines in response to <italic>Listeria</italic> infection with or without IFNγ treatment. Compared to control cells, HOIL-1 KO macrophages secreted only 50%, 20% and 10% of the expected levels of TNFα, IL-6 and IL-12p70 protein, respectively (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistent with a role for HOIL-1 in the activation of the NF-κB transcription factor following TLR stimulation, <italic>Listeria-</italic>infected HOIL-1 KO macrophages expressed decreased levels of <italic>Tnf</italic>, <italic>Il6</italic> and <italic>Il12b</italic> mRNA (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The defects in cytokine transcript levels were of smaller magnitude than the decreases in secreted protein, particularly for <italic>Tnf</italic>, suggesting that HOIL-1 may also be involved in cytokine translation or secretion. However, HOIL-1 KO macrophages killed <italic>Listeria</italic> after activation with IFNγ as effectively as control cells, indicating the selectivity of HOIL-1 effects on macrophage function (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.04494.015</object-id><label>Figure 3.</label><caption><title>HOIL-1 is important for induction of pro-inflammatory cytokines following <italic>Listeria</italic> infection.</title><p>(<bold>A</bold>) TNFα (6 hr), IL-6 (6 hr) and IL-12p70 (24 hr) protein in macrophage culture supernatants following infection with <italic>Listeria</italic> (LM) ± IFNγ co-treatment. (<bold>B</bold>) Induction of <italic>Tnf</italic>, <italic>Il6</italic> and <italic>Il12b</italic> transcripts in macrophages over 12 hr following infection with <italic>Listeria</italic> plus IFNγ. Data represent the mean ± SEM of macrophages derived from two mice per genotype analyzed in triplicate and are representative of at least three independent experiments. (<bold>C</bold>) Induction of cytokine transcripts in peritoneal cells over 12 hr following infection of control (blue circles) and HOIL-1 KO (red squares) mice with 10<sup>5</sup> <italic>Listeria</italic>. Each symbol represents an individual mouse. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Statistical analyses were performed using <italic>t</italic>-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.015">http://dx.doi.org/10.7554/eLife.04494.015</ext-link></p></caption><graphic xlink:href="elife-04494-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.016</object-id><label>Figure 3—figure supplement 1.</label><caption><title>HOIL-1 is not required for listericidal activity of bone marrow-derived macrophages.</title><p>Growth and killing of <italic>Listeria</italic> in untreated or IFNγ-pre-treated control and HOIL-1 KO macrophages at 0 and 6 hr post-infection. Data are from two independent experiments performed in duplicate.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.016">http://dx.doi.org/10.7554/eLife.04494.016</ext-link></p></caption><graphic xlink:href="elife-04494-fig3-figsupp1-v1"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.017</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Analysis of peritoneal cell populations following <italic>Listeria</italic> infection.</title><p>Flow cytometric analysis of peritoneal cell populations in control (blue circles; 0 hr <italic>n</italic> = 20, 6 hr <italic>n</italic> = 10, 12 hr <italic>n</italic> = 7) and HOIL-1 KO mice (red squares; 0 hr <italic>n</italic> = 9, 6 hr <italic>n</italic> = 12, 12 hr <italic>n</italic> = 7) over 12 hr after infection with 10<sup>5</sup> CFU i.p. Data represent the mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Statistical analyses were performed using <italic>t</italic>-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.017">http://dx.doi.org/10.7554/eLife.04494.017</ext-link></p></caption><graphic xlink:href="elife-04494-fig3-figsupp2-v1"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.018</object-id><label>Figure 3—figure supplement 3.</label><caption><title>HOIL-1 is important for induction of pro-inflammatory cytokines by innate cells following <italic>Listeria</italic> infection in vivo.</title><p>Induction of cytokine transcripts in peritoneal cells from uninfected (0 hr) RAG1 KO HOIL-1 WT (blue circles) and RAG1 KO HOIL-1 KO (red squares) mice or 3 hr after infection with 10<sup>4</sup> <italic>Listeria</italic>. Each symbol represents an individual mouse.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.018">http://dx.doi.org/10.7554/eLife.04494.018</ext-link></p></caption><graphic xlink:href="elife-04494-fig3-figsupp3-v1"/></fig></fig-group></p><p>We confirmed that induction of <italic>Tnf</italic> and <italic>Il6</italic> mRNA was significantly impaired following <italic>Listeria</italic> infection in vivo by measuring cytokine transcripts in peritoneal cells from mice 3 to 12 hr after infection (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This reduction in cytokine transcripts could not be explained by a decrease in macrophage numbers (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Surprisingly, <italic>Il12b</italic> transcript levels were similar in HOIL-1 KO mice, with a significant difference being detected at only 6 hr after infection. Similar decreases in <italic>Tnf</italic> and <italic>Il6</italic> mRNA were observed in mice on the <italic>Rag1</italic><sup><italic>−/−</italic></sup> background at 3 hr post-infection, confirming that these differences are due to a defect in innate immunity in the absence of HOIL-1 (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). We also noted that fewer NK cells and neutrophils were present in the peritoneum 6 hr after <italic>Listeria</italic> infection, suggesting delayed recruitment or proliferation of these cell types (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). These decreases in cytokine production and delayed cell recruitment likely synergize with defects in IL-1β and TNFα signaling observed by others (<xref ref-type="bibr" rid="bib30">Tian et al., 2007</xref>; <xref ref-type="bibr" rid="bib9">Haas et al., 2009</xref>; <xref ref-type="bibr" rid="bib34">Tokunaga et al., 2009</xref>, <xref ref-type="bibr" rid="bib32">2011</xref>) to compromise antibacterial immunity, and may contribute to the impaired induction of <italic>Ifng</italic> mRNA observed by 12 hr (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). These data indicate that HOIL-1 plays a critical role in coordinating essential early cytokine responses after <italic>Listeria</italic> infection.</p></sec><sec id="s2-4"><title>HOIL-1 KO mice display enhanced control of murine gamma-herpesvirus 68 and <italic>Mycobacterium tuberculosis</italic> and a hyperinflammatory response to infection</title><p>The above data demonstrate that HOIL-1 KO mice have a severe immunodeficiency after certain types of infection. To assess the generality of this phenotype we infected HOIL-1 KO mice with murine γ-herpesvirus 68 (MHV68), a genetic relative of the common persistent human herpesviruses, Epstein–Barr virus and Kaposi's sarcoma-associated herpesvirus (EBV, KSHV) (<xref ref-type="bibr" rid="bib1">Barton et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Speck and Ganem, 2010</xref>). HOIL-1 KO mice survived MHV68 infection for at least 3 months. MHV68 replication was unaffected by HOIL-1 deficiency in cultured macrophages, and was suppressed only slightly in vivo (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Despite normal establishment of latency as determined by the number of cells carrying MHV68 genome 28 days after infection (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), the efficiency of MHV68 reactivation from latency in explanted peritoneal cells was significantly impaired (approximately 50-fold, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Similarly, HOIL-1 KO mice failed to succumb to infection with <italic>M. tuberculosis</italic> over 70 days of infection, and in fact exhibited lower bacterial colony counts in the spleen while counts in the lung were no different than controls (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Thus HOIL-1 KO mice are fully able to control, and may have an enhanced ability to control, specific aspects of acute and chronic MHV68 and <italic>M. tuberculosis</italic> infection, in striking contrast to the immunodeficiency apparent after infection with <italic>Listeria, Toxoplasma</italic>, and <italic>Citrobacter</italic>.<fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.04494.003</object-id><label>Figure 4.</label><caption><title>Enhanced inflammatory response and control of MHV68 and <italic>M. tuberculosis</italic> by HOIL-1 KO mice.</title><p>(<bold>A</bold>) Limiting dilution assay of peritoneal cells from control (blue circles) and HOIL-1 KO (red squares) mice infected with MHV68 for 28 days onto mouse embryonic fibroblast monolayers to measure the frequency of cells capable of MHV68 reactivation. The dashed line indicates 63.2%, which was used to determine the frequency of cells reactivating virus by the Poisson distribution. Data represent the mean from three independent experiments each with cells combined from three mice/group. *p ≤ 0.05. Statistical analyses were performed by calculating the number of control and HOIL-1 KO cells required for 63.2% of wells to contain complete cytopathic effect for each individual experiment by non-linear regression, then comparing these values by paired <italic>t</italic>-test. Preformed virus was not detected in disrupted samples (not shown). (<bold>B</bold>) <italic>M. tuberculosis</italic> titers in the lung and spleen of HOIL-1 KO (red squares) and control (blue circles) mice 70 days post-infection. *p ≤ 0.05. Statistical analyses were performed using <italic>t</italic>-test. (<bold>C</bold>) TNFα, IL-6, IL-12/IL-23p40 and IFNγ protein detected in serum from naïve or latently-infected (28 days) control (blue circles) and HOIL-1 KO (red squares) mice. Each symbol represents an individual mouse and the mean is indicated. *p ≤ 0.05, <italic>t</italic>-test with Welch's correction (IL-12/IL-23p40) or Mann Whitney test (TNFα, IL-6, IFNγ). (<bold>D</bold>) TNFα, IL-6, IL-12/IL-23p40 and IFNγ protein in serum from mice from (<bold>B</bold>). Each symbol represents an individual mouse. Data are combined from two independent experiments. *p ≤ 0.05, **p ≤ 0.01. Statistical analyses were performed using <italic>t</italic>-test (TNFα, IL-12p40) with Welch's correction (IFNγ) or Mann Whitney test (IL-6).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.003">http://dx.doi.org/10.7554/eLife.04494.003</ext-link></p></caption><graphic xlink:href="elife-04494-fig4-v1"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.004</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Acute MHV68 replication in vitro and in vivo is minimally affected by HOIL-1-deficiency.</title><p>(<bold>A</bold>) MHV68 growth in HOIL-1 KO (red symbols) and control (blue symbols) bone marrow-derived macrophages with (squares) or without (circles) IFNγ pre- and post-treatment. Data represent the mean ± SEM from three independent experiments performed in triplicate. (<bold>B</bold>) MHV68 titers in spleen during acute infection of HOIL-1 KO (red squares) and control (blue circles) mice. **p ≤ 0.01, Mann Whitney test. The dashed line indicates the limit of detection.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.004">http://dx.doi.org/10.7554/eLife.04494.004</ext-link></p></caption><graphic xlink:href="elife-04494-fig4-figsupp1-v1"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.005</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Establishment of MHV68 latency is similar in control and HOIL-1 KO mice.</title><p>Limiting dilution PCR to determine the frequency of peritoneal cells from latently infected (28 days) HOIL-1 KO (red squares) and control (blue circles) mice containing MHV68 genomes. The dashed line indicates 63.2%, which was used to determine the frequency of cells containing viral genome by the Poisson distribution. Data represent the mean from three independent experiments each with cells combined from three mice/group. Statistical analyses were performed by calculating the number of control and HOIL-1 KO cells required for 63.2% of reactions to be positive for viral genome for each individual experiment by non-linear regression, then comparing these values by paired <italic>t</italic>-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.005">http://dx.doi.org/10.7554/eLife.04494.005</ext-link></p></caption><graphic xlink:href="elife-04494-fig4-figsupp2-v1"/></fig></fig-group></p></sec><sec id="s2-5"><title>Environmental control of HOIL-1 deficiency-associated phenotypes</title><p>The ability of HOIL-1 KO mice to effectively control chronic herpesvirus infection allowed us to test the hypothesis that persistent virus infection might alter two phenotypes, hyper-inflammation and immunodeficiency, in which HOIL-1 KO mice appear to differ from some reported patients with bi-allelic mutations in <italic>RBCK1</italic> (<italic>HOIL1</italic>) (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>). Notably, patients with HOIL-1 deficiency and hyper-inflammation exhibited increased expression of IL-6 and TNFα in the serum and increased expression of mRNA for <italic>Il6</italic> in blood cells (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>). We therefore examined the serum of MHV68-infected HOIL-1 KO mice for cytokines essential for resistance to <italic>Listeria</italic> but deficient in <italic>Listeria</italic>-infected HOIL-1 KO mice. As previously observed (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>), latent infection of control mice with MHV68 was associated with an increase in circulating levels of TNFα, IL-6, IL-12 and IFNγ compared with uninfected mice (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In HOIL-1 KO mice, MHV68 latently resulted in small but significant increases in TNFα, IL-6 and IL-12p70 levels, and a more striking increase in IFNγ levels compared to latently infected controls. HOIL-1 KO mice chronically infected with <italic>M. tuberculosis</italic> also exhibited increased expression of both IL-6 and TNFα in serum at 70 days post-infection (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Therefore, there is an overlap between cytokines expressed in hyper-inflammatory patients and in chronically-infected HOIL-1 KO mice.</p></sec><sec id="s2-6"><title>Latent infection with murine gamma-herpesvirus 68 protects HOIL-1 deficient mice from <italic>Listeria</italic>-induced lethality</title><p>MHV68 latency has been shown previously to induce symbiotic protection against <italic>Listeria</italic> infection in wild-type mice (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>). Because expression of TNFα, IL-6 and IFNγ are essential for control of <italic>Listeria</italic> infection in mice (<xref ref-type="bibr" rid="bib16">Kopf et al., 1994</xref>; <xref ref-type="bibr" rid="bib36">Unanue, 1997</xref>; <xref ref-type="bibr" rid="bib45">Williams et al., 2012</xref>), and were impaired in <italic>Listeria</italic>-infected HOIL-1 KO mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), but elevated in MHV68-infected HOIL-1 KO mice, we considered whether chronic MHV68 infection could complement the profound immunodeficiency observed in <italic>Listeria</italic>-infected barrier-raised HOIL-1 KO mice. As observed previously (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>), MHV68 latency, 1 month after infection, protected control mice from an otherwise lethal dose of <italic>Listeria</italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). MHV68 latency also protected HOIL-1 KO mice from a dose of <italic>Listeria</italic> at least 1000-fold higher than the LD<sub>50</sub> for MHV68-negative mice (<xref ref-type="fig" rid="fig1 fig5">Figures 5A and 1A</xref>). Both control and HOIL-1 KO mice were still partially protected from <italic>Listeria</italic> challenge 6 months after MHV68 infection (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). A viral mutant capable of acute lytic infection but unable to efficiently establish latency (ORF73.stop) (<xref ref-type="bibr" rid="bib18">Moorman et al., 2003</xref>) was unable to efficiently protect HOIL-1 KO or control mice from <italic>Listeria</italic> infection, demonstrating that latent MHV68 is required to complement HOIL-1-associated immunodeficiency to <italic>Listeria</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).<fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.04494.019</object-id><label>Figure 5.</label><caption><title>MHV68 latency rescues HOIL-1 KO, IL-6, Caspase-1 and Caspase-1;Caspase-11-deficient mice from <italic>Listeria</italic>-induced lethality.</title><p>(<bold>A</bold>) Survival of control (blue symbols; mock <italic>n</italic> = 9, MHV68 <italic>n</italic> = 15) and HOIL-1 KO (red symbols; mock <italic>n</italic> = 10, MHV68 <italic>n</italic> = 20) mice challenged with 10<sup>6</sup> CFU <italic>Listeria</italic> 28 days following mock infection (circles) or infection with 10<sup>6</sup> PFU MHV68 (squares). *p ≤ 0.0083; logrank Mantel–Cox test corrected for multiple comparisons. (<bold>B</bold>) Survival of control (blue symbols) and HOIL-1 KO (red symbols) mice challenged with 10<sup>6</sup> CFU <italic>Listeria</italic> 28 days following intranasal mock infection (circles) or infection with 5 × 10<sup>4</sup> PFU wild-type (squares) or ORF73.stop (triangles) MHV68. Significantly different groups were: control mock infected and control MHV68wt infected, control mock infected and HOIL-1 KO MHV68wt infected, control mock infected and HOIL-1 KO MHV68orf73.stop infected, HOIL-1 KO mock infected and control MHV68wt infected, HOIL-1 KO mock infected and HOIL-1 KO MHV68wt infected, control MHV68wt infected and control MHV68orf73.stop infected, control MHV68wt infected and HOIL-1 KO MHV68orf73.stop infected, HOIL-1 KO MHV68wt infected and control MHV68orf73.stop infected, HOIL-1 KO MHV68wt infected and HOIL-1 KO MHV68orf73.stop infected, control MHV68orf73.stop infected and HOIL-1 KO MHV68orf73.stop infected. *p ≤ 0.0033; logrank Mantel–Cox test corrected for multiple comparisons. (<bold>C</bold>) Cytokine transcript levels in peritoneal cells from mock (circles) and MHV68-infected (squares) control (blue symbols) and HOIL-1 KO (red symbols) mice (28 days post-infection). (<bold>D</bold>) Induction of cytokine transcripts in peritoneal cells from mock (circles) and MHV68-infected (squares) control (blue symbols) and HOIL-1 KO (red symbols) mice (28 days) 3 hr after infection with 10<sup>5</sup> <italic>Listeria</italic>. Each symbol represents an individual mouse. For (<bold>C</bold>) and (<bold>D</bold>), *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Statistical analyses were performed using one-way ANOVA. (<bold>E</bold>) Survival of control (blue symbols) and <italic>Il6</italic><sup><italic>−/−</italic></sup> (purple symbols) mice challenged with 10<sup>6</sup> CFU <italic>Listeria</italic> 28 days following mock infection (circles) or infection with 10<sup>6</sup> PFU MHV68 (squares). *p ≤ 0.0083; logrank Mantel–Cox test corrected for multiple comparisons. (<bold>F</bold>) Survival of control (blue symbols), Caspase-1;Caspase-11 (orange symbols) and Caspase-1 (green symbols) –deficient mice challenged with 10<sup>6</sup> CFU <italic>Listeria</italic> 28 days following mock infection (circles) or infection with 10<sup>6</sup> PFU MHV68 (squares). *p ≤ 0.0033; logrank Mantel–Cox test corrected for multiple comparisons.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.019">http://dx.doi.org/10.7554/eLife.04494.019</ext-link></p></caption><graphic xlink:href="elife-04494-fig5-v1"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.020</object-id><label>Figure 5—figure supplement 1.</label><caption><title>MHV68 latency-induced cross-protection is maintained for at least 6 months.</title><p>Survival of control (blue symbols) and HOIL-1 KO (red symbols) mice challenged with 10<sup>6</sup> CFU <italic>Listeria</italic> 6 months after mock infection (circles) or infection with 10<sup>6</sup> PFU MHV68 (squares). Statistical analyses were performed by logrank Mantel–Cox test corrected for multiple comparisons, with p ≤ 0.0083 considered significant. Control mock vs HOIL-1 KO mock, p = 0.1824; control mock vs control MHV68 infected, p = 0.0408; control mock vs HOIL-1 KO MHV68 infected, p = 0.0070; HOIL-1 KO mock vs control MHV68 infected, p = 0.0028; HOIL-1 KO mock vs HOIL-1 KO MHV68 infected, p = 0.0003; control MHV68 infected vs HOIL-1 KO MHV68 infected, p = 0.9303.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.020">http://dx.doi.org/10.7554/eLife.04494.020</ext-link></p></caption><graphic xlink:href="elife-04494-fig5-figsupp1-v1"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.021</object-id><label>Figure 5—figure supplement 2.</label><caption><title>MHV68 latency enhances the listericidal activity of peritoneal macrophages.</title><p><italic>Listeria</italic> CFU in control (blue symbols) and HOIL-1 KO (red symbols) <italic>ex vivo</italic> cultures of peritoneal macrophages from mock (circles) or MHV68-infected (32 days, squares) mice at 0 and 6 hr post-infection. Data are combined from two independent experiments. Each symbol represents an individual mouse analyzed in duplicate. Cells from the same mouse were used for both 0 hr and 6 hr time points. Statistical analyses were performed by one-way ANOVA with Holm-Sidak's multiple comparison test for each time point.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.021">http://dx.doi.org/10.7554/eLife.04494.021</ext-link></p></caption><graphic xlink:href="elife-04494-fig5-figsupp2-v1"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.04494.022</object-id><label>Figure 5—figure supplement 3.</label><caption><title><italic>Il6<sup>−/−</sup></italic> mice have increased susceptibility to Listeria infection.</title><p>Survival of control (blue circles) and <italic>Il6</italic><sup><italic>−/−</italic></sup> (purple squares) mice following i.p. inoculation with 10<sup>5</sup> CFU <italic>Listeria</italic>. *p ≤ 0.0083; logrank Mantel–Cox test corrected for multiple comparisons.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04494.022">http://dx.doi.org/10.7554/eLife.04494.022</ext-link></p></caption><graphic xlink:href="elife-04494-fig5-figsupp3-v1"/></fig></fig-group></p></sec><sec id="s2-7"><title>Mechanism of virus-associated protection of HOIL-1 KO mice</title><p>To determine whether MHV68 latency rescued pro-inflammatory cytokine induction by HOIL-1 KO mice following <italic>Listeria</italic> infection, we quantitated cytokine transcripts in peritoneal cells from latently infected mice before (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) and 3 hr after (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) infection with <italic>Listeria</italic>. As predicted from the cytokine levels in the serum, MHV68 latency resulted in small but significant increases in <italic>Tnf, Il6 and Il12b</italic> transcripts prior to <italic>Listeria</italic> challenge (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). While MHV68 latency did not rescue the induction of <italic>Tnf</italic> or <italic>Il6</italic> transcripts in HOIL-1 KO mice following infection with <italic>Listeria</italic>, <italic>Il12b</italic> transcript levels were increased approximately twofold, and were comparable to levels in control mice. More significantly, <italic>Ifng</italic> and <italic>Nos2</italic> (encoding iNOS) transcripts were elevated approximately 200-fold and 1000-fold, respectively, in latently infected control and HOIL-1 KO mice (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), and further induced by 3 hr after infection with <italic>Listeria</italic> (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). <italic>Ifng</italic> transcript levels were significantly higher in latently infected HOIL-1 KO mice following infection with <italic>Listeria</italic> than in control mice. These data suggest that MHV68 latency by-passes the requirement for TNFα and IL-6 during early <italic>Listeria</italic> infection by enhancing the induction of IFNγ and downstream effector molecules important for controlling <italic>Listeria</italic> infection.</p><p>To test whether peritoneal macrophages from latently infected HOIL-1 KO mice had an increased capacity to kill <italic>Listeria</italic>, we explanted peritoneal macrophages from mock or latently infected mice, infected them with <italic>Listeria</italic>, killed extracellular bacteria with gentamycin treatment, and compared the number of CFU at 6 hr to the number of CFU at the beginning of the experiment. As expected, cells from mock infected control mice exhibited mild listericidal activity and cells from latently infected control mice had an enhanced ability to kill <italic>Listeria</italic> (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>, (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>)). Macrophages from mock-infected HOIL-1 KO mice had a slightly impaired ability to control <italic>Listeria</italic> infection. However, MHV68 latency in HOIL-1 KO mice enhanced the ability of macrophages to kill <italic>Listeria</italic>, generating a capacity to kill similar to that observed with macrophages from control mice. Together, these data suggest that MHV68 latency induces an environment that enhances the ability of HOIL-1-deficient cells to kill and respond to <italic>Listeria</italic>.</p></sec><sec id="s2-8"><title>Viral complementation of multiple genetic immunodeficiencies</title><p>To determine whether the viral complementation of immunodeficiency was unique to HOIL-1, we latently infected IL-6, Caspase-1-deficient and Caspase-1;Caspase-11-double-deficient mice (<xref ref-type="bibr" rid="bib15">Kayagaki et al., 2013</xref>), which survive MHV68 infection but are all highly susceptible to <italic>Listeria</italic> infection (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>) (<xref ref-type="bibr" rid="bib16">Kopf et al., 1994</xref>; <xref ref-type="bibr" rid="bib24">Sarawar et al., 1998</xref>; <xref ref-type="bibr" rid="bib7">Edelson and Unanue, 2002</xref>; <xref ref-type="bibr" rid="bib35">Tsuji et al., 2004</xref>; <xref ref-type="bibr" rid="bib26">Sauer et al., 2011</xref>). IL-6, Caspase-1 and Caspase-1;Caspase-11-deficient mice were also protected from lethality following <italic>Listeria</italic> infection by chronic MHV68 infection (<xref ref-type="fig" rid="fig5">Figure 5E,F</xref>). These data indicate that the capacity of chronic MHV68 to reverse a significant immunodeficiency is not restricted to mutations in <italic>Rbck1</italic> (<italic>Hoil1</italic>), and suggest that chronic viral infections may alter phenotypes of many host allelic variants.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We report that HOIL-1 is essential during infection with <italic>Listeria</italic>, <italic>T. gondii</italic> and <italic>C. rodentium</italic>, but not with MHV68 or <italic>M. tuberculosis</italic> in mice. Expression of HOIL-1 was critical in innate, hematopoietic-derived cells during <italic>Listeria</italic> infection in vivo<italic>.</italic> The requirement of HOIL-1 for the induction of protective inflammatory cytokines, TNFα, IL-6 and IL-12, following infection of macrophages with <italic>Listeria</italic> in vitro is consistent with reports that LUBAC is required for efficient NF-κB activation following TLR engagement (<xref ref-type="bibr" rid="bib47">Zak et al., 2011</xref>; <xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>), but not with a recent report that NF-κB activation following stimulation of TLR4 and TNF-R1 on macrophages by LPS and TNFα, respectively, is unaffected by HOIL-1 deficiency (<xref ref-type="bibr" rid="bib22">Rodgers et al., 2014</xref>). These apparently conflicting results suggest that HOIL-1 and LUBAC may not only have cell-type specific functions (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Rodgers et al., 2014</xref>), but also stimulus-specific roles that vary between different cell types. This may be further highlighted by the excessive inflammatory response and enhanced control of MHV68 and <italic>M. tuberculosis</italic> infection—two pathogens that also infect macrophages—by HOIL-1-deficient mice. It has been proposed that low levels of viral reactivation during MHV68 latency are responsible for the low level of constant immune activation and cytokine production (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>). It is paradoxical, then, that reactivation is almost undetectable in HOIL-1-deficient animals, and yet their inflammatory response is elevated. Since the negative regulator of NF-κB signaling, A20, binds to linear ubiquitin chains (<xref ref-type="bibr" rid="bib33">Tokunaga et al., 2012</xref>; <xref ref-type="bibr" rid="bib37">Verhelst et al., 2012</xref>), HOIL-1/LUBAC may also be important for recruiting A20 to receptor signaling complexes to turn off signaling. Therefore, receptor signaling may be sustained in cells in HOIL-1 KO mice, resulting in the increase in TNFα, IL-6 and IL-12, and ultimately IFNγ protein, observed in the serum of chronically infected mice. Decreased viral reactivation may be the result of this increased IFNγ, the inability of latently infected cells to response to a stimulus of reactivation or a combination thereof.</p><p>It is unclear why HOIL-1 KO mice are extremely susceptible to some pathogens, yet control other infections remarkably well. This might be due to HOIL-1/LUBAC having differential roles in transducing signals from different immune sensors stimulated by different infections. Other possibilities include a differential requirement for the innate immune system to hold the acute infection in check while an adaptive response is being generated, the speed at which the pathogen replicates, the tissues that it damages, and whether pathology during acute infection is mostly immune- or pathogen-derived. Further studies will be required to address these possibilities.</p><p>We further show that chronic infection with MHV68 rescued HOIL-1, IL-6, Caspase-1 and Caspase-1;Caspase-11-deficient mice from lethal <italic>Listeria</italic> infection, thereby masking the genetic immunodeficiency observed in MHV68-negative mice. As reported previously (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>), MHV68 latency was associated with increased basal levels of pro-inflammatory cytokines TNFα, IL-6, IL-12 and IFNγ in the serum of wild-type animals, which were further increased in HOIL-1 KO mice. These cytokines appear to increase the activation status of the innate immune system such that their induction following <italic>Listeria</italic> infection is no longer as important as would be the case in a naïve mouse. Indeed, MHV68 infection did not enhance the transcription of <italic>Tnf</italic>, and only marginally enhanced the transcription of <italic>Il6</italic> and <italic>Il12b</italic> even in control mice following <italic>Listeria</italic> infection, and did not rescue the defect in <italic>Tnf</italic> and <italic>Il6</italic> induction observed in HOIL-1 KO mice. Conversely, transcription of <italic>Ifng</italic> and the effector molecule, <italic>iNOS (</italic>encoded by <italic>Nos2)</italic>, was elevated in cells from latently infected mice and enhanced substantially by both HOIL-1 KO and control animals very rapidly following infection with <italic>Listeria</italic>. Macrophages require priming with IFNγ to induce IL-12 in response to <italic>Listeria</italic> infection. In a latently infected animal, IFNγ is already present and so IL-12 and additional IFNγ may be induced more rapidly. Furthermore, as reported previously for wild-type mice (<xref ref-type="bibr" rid="bib2">Barton et al., 2007</xref>), MHV68 latency enhanced the ability of peritoneal macrophages from control and HOIL-1 KO mice to kill <italic>Listeria</italic>. Together, these data suggest that the constant presence of low levels of IFNγ driven by latent virus infection results in an increase in the basal expression levels of downstream effector molecules and the priming of cells for the enhanced immediate killing of <italic>Listeria</italic> upon infection, as well as for a more rapid further induction of IFNγ and its effector molecules in response to the bacterial challenge. In this sense, chronic virus infection sets the level of innate immunity to subsequent infection.</p><p>HOIL-1 KO mice bred in a high grade barrier facility failed to exhibit certain phenotypes of HOIL-1 deficient patients, specifically by not exhibiting baseline hyper-inflammation and by displaying a striking immunodeficiency out of proportion to that observed in some humans with bi-allelic mutations in <italic>RBCK1</italic> (<italic>HOIL1</italic>). Most humans are infected life-long with multiple herpesviruses (<xref ref-type="bibr" rid="bib40">Virgin et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Virgin, 2014</xref>), and many also carry other chronic or latent infections such as tuberculosis. Importantly, we observed complementation of immunodeficiency to <italic>Listeria</italic> by chronic herpesvirus infection in four different strains of immunodeficient mice, revealing virus infection as one possible environmental factor that might alter the genotype-phenotype relationship for patients with mutations in immune system genes. HOIL-1 KO mice chronically infected with either a herpesvirus or <italic>M. tuberculosis</italic> also exhibited increases in some of the same cytokines reported in the serum of HOIL-1 deficient humans. At least three of the HOIL-1 mutant patients were infected with at least one herpesvirus (<xref ref-type="bibr" rid="bib4">Boisson et al., 2012</xref>), and it is likely that other chronic infections were present. However, in the absence of data regarding the complete infection status of the HOIL-1 mutant patients, the relevance of the mouse studies to the human phenotypes is unclear. Nevertheless, perhaps the presence of the virome, and potentially variations in the virome or other chronic infections between people, confers significant phenotypic variation by complementing mutations in host genes responsible for innate immunity (<xref ref-type="bibr" rid="bib38">Virgin, 2014</xref>).</p><p>The genes involved in immunity and inflammation are the most rapidly evolving in the mammalian genome (<xref ref-type="bibr" rid="bib17">Lindblad-Toh et al., 2011</xref>; <xref ref-type="bibr" rid="bib5">Casanova et al., 2013</xref>; <xref ref-type="bibr" rid="bib21">Quintana-Murci and Clark, 2013</xref>). Survival from infection requires a trade-off between alleles that promote or limit inflammation to balance immunity vs immunopathology. We speculate that the virome or other chronic infections hide or enhance the effects of genetic variations in immune responsiveness by complementing chromosomal variations in immune response genes. As the nature of the virome changes in persons growing up in different cultural and economic environments, it is possible that the immunophenotype of the host changes, and the beneficial or deleterious effects of existing genetic variation are unmasked by removal of complementation provided by chronic virus infection. It is also plausible that the striking auto-inflammation observed in humans with a variety of immune defects could be due to even well controlled herpesvirus infection alone or in combination with other chronic infections. Our data suggest that analysis of the metagenome, including the virome, may be of value in linking human phenotype and genotype (<xref ref-type="bibr" rid="bib38">Virgin, 2014</xref>; <xref ref-type="bibr" rid="bib39">Virgin and Todd, 2011</xref>). Recent rapid advances in sequencing and analysis of the metagenome will make integration of data from the virome into human genetic studies practical (<xref ref-type="bibr" rid="bib38">Virgin, 2014</xref>).</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>HOIL-1 KO mice, with null mutations in the <italic>Rbck1</italic> gene that encodes HOIL-1, have been described previously (<xref ref-type="bibr" rid="bib34">Tokunaga et al., 2009</xref>). C57BL/6J mice or HOIL-1 WT littermates were used as wild type controls. <italic>Rag1</italic><sup><italic>−/−</italic></sup> mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and bred to HOIL-1 KO mice. <italic>Il6</italic><sup><italic>−/−</italic></sup> mice were purchased from The Jackson Laboratory. Caspase 1;Caspase 11-deficient mice with or without a Caspase 11 transgene were kindly provided by Vishva Dixit, Genentec, San Francisco USA. All mice were housed and bred at Washington University in Saint Louis in specific pathogen-free conditions in accordance with Federal and University guidelines and protocols were approved by the Animal Studies Committee of Washington University under protocol number 20140244. Mice were inoculated between 8 and 11 weeks of age.</p></sec><sec id="s4-2"><title>In vivo infections</title><p><italic>L. monocytogenes</italic> wild type strain EGD was used for this study. <italic>Listeria</italic> glycerol stocks were stored at −80 °C, and thawed and diluted into PBS for intraperitoneal (i.p.) injection into mice. To determine tissue burden, spleens and livers were homogenized in 10 ml PBS containing 0.05% Triton X-100 and serial dilutions were plated on brain heart infusion agar plates. <italic>Listeria</italic> CFU were counted after overnight growth at 37°C. Small sections of spleen and liver were also fixed in 10% buffered formalin for histological analysis.</p><p>The type II Prugniaud strain of <italic>T. gondii</italic> expressing a firefly luciferase (PRU-Fluc-GFP, provided by J. Boothroyd, Stanford University, Palo Alto, CA) (<xref ref-type="bibr" rid="bib23">Saeij et al., 2005</xref>) was used in all in vivo <italic>T. gondii</italic> experiments. Tachyzoites were grown by 2-day serial passage in human foreskin fibroblasts. For infections, freshly egressed parasites were filtered, counted, and injected i.p. into mice.</p><p>Mice were with inoculated orally with 2 × 10<sup>9</sup> CFU <italic>C. rodentium</italic> strain DBS100 (ATCC, Manassas, VA) from a fresh culture and monitored for morbidity and mortality.</p><p>MHV68 WUMS (ATCC VR1465), MHV68 ORF73.stop and γHV68 M3-Fluc were passaged and titered by plaque assay on NIH 3T12 cells. Virus stocks were stored at −80 °C, and thawed and diluted into PBS for i.p. or intranasal (i.n.) inoculation of mice. For experiments involving MHV68 ORF73.stop, i.n. inoculation with 5 × 10<sup>4</sup> CFU was performed due to the low titer of the virus stock. To determine γHV68 titers in tissues, organs were placed in 1 ml of complete DMEM and frozen at −80°C. Samples were thawed prior to disruption with silica beads and virus titration by plaque assay.</p><p>Before infection, exponentially replicating <italic>M. tuberculosis</italic> Erdman strain bacteria were washed in PBS + 0.05% Tween 80, and sonicated to disperse clumps. Mice were exposed to 8 × 10<sup>7</sup> CFU of <italic>M. tuberculosis</italic> in an Inhalation Exposure System (Glas-Col, Terre Haute, IN), which delivers ∼100 bacteria to the lung per animal. After 24 hr post infection, two mice per group were sacrificed, and lungs were harvested to determine infection efficiency, which was about 100 CFU/lung/mouse. Experimental mice were sacrificed 70 days after infection, and lungs and spleen were harvested for CFU, and serum was collected for cytokine analysis. Bacterial burdens were determined by plating serial dilutions of lung and spleen homogenates onto 7H10 agar plates and incubated at 37°C in 5% CO<sub>2</sub> for 3 weeks prior to counting colonies.</p></sec><sec id="s4-3"><title>MHV68 <italic>ex vivo</italic> limiting dilution assay for reactivation from latency and limiting dilution PCR for viral genomes</title><p>MHV68 reactivation from latency and preformed virus was assayed as described previously (<xref ref-type="bibr" rid="bib42">Weck et al., 1996</xref>). Briefly, peritoneal exudate cells were plated in twofold serial dilutions (24-wells per dilution) onto permissive mouse embryonic fibroblast (MEF) monolayers and scored for cytopathic effect (CPE) 3 weeks later. Reactivation of lytic virus from a peritoneal cell leads to complete CPE of the MEF monolayer. To measure preformed infectious virus in the sample, parallel samples of cells were mechanically disrupted to kill the cells but keep any infectious virus intact. These samples were plated and scored as described above. Using the Poisson distribution, CPE in 63.2% of wells indicates that one reactivation event is likely to have occurred per well, and is used to determine the frequency of reactivating cells in the sample.</p><p>To determine the frequency of cells harboring viral genome, peritoneal cells were assayed by nested PCR for viral genome as described previously (<xref ref-type="bibr" rid="bib43">Weck et al., 1999</xref>). The detection of PCR product in 63.2% of wells indicates that one genome was present per well.</p></sec><sec id="s4-4"><title>Cells and infections</title><p>Primary bone marrow-derived macrophages were prepared as described previously (<xref ref-type="bibr" rid="bib13">Hwang et al., 2012</xref>). Briefly, bone marrow was extracted from mouse femurs and allowed to differentiate in DMEM containing 10% FBS, 10% CMG14-12 cell-conditioned media as a source of M-CSF (<xref ref-type="bibr" rid="bib29">Takeshita et al., 2000</xref>), 5% horse serum, 1 mM sodium pyruvate and 2 mM L-Glutamine for 7 days.</p><p>For cytokine and transcript analyses following <italic>Listeria</italic> infection of macrophages, adherent cells were scraped and seeded in tissue culture-treated plates in the absence of M-CSF. After 3 days, macrophages were infected with 10<sup>6</sup>/ml <italic>Listeria</italic> in the presence or absence of 100 U/ml IFNγ. 2 hr post-infection, 50 U/ml Penicillin and 50 μg/ml streptomycin were added to kill the <italic>Listeria</italic>. Cell supernatants were harvested at indicated times and frozen at −80 °C prior to cytokine analysis. Cells were lyzed in TRI-Reagent for RNA extraction.</p><p>For <italic>Listeria</italic> growth/killing assays, macrophages were seeded in non-tissue culture treated dishes in the absence of M-CSF. After 1 day, cells were treated with 300 µ/ml IFNγ or untreated, and 48 hr later scraped replated on sterile coverslips. After 3 hr, cells were infected with 10<sup>5</sup>/ml <italic>Listeria</italic> from an overnight standing culture and centifuged to synchronize the infection. 50 μg/ml gentamycin was added after 30 min to kill extracellular bacteria. At the indicated times, coverslips were washed with warm PBS, then lyzed in 10 ml cold water to release the bacteria. Serial dilutions were plated on brain heart infusion agar plates, and <italic>Listeria</italic> CFU were counted after overnight growth at 37°C.</p><p>For MHV68 growth analysis, adherent cells were scraped and seeded in tissue culture-treated plates in the presence of M-CSF. After 2 days, macrophages were treated with 0.1 U/ml IFNγ or untreated, and 12 hr later infected with MHV68 at a multiplicity of infection (MOI) of 0.05 for 1 hr with occasional rocking at 37°C and 5% CO<sub>2</sub>. Cells were washed once with medium and incubated in DMEM supplemented with 10% FBS and 2 mM L-glutamine (with or without 0.1 U/ml IFNγ) for the indicated period of time at 37°C and 5% CO<sub>2</sub>, before being frozen at −80 °C. Virus titers were determined by plaque assay following two freeze–thaw cycles.</p></sec><sec id="s4-5"><title>Analysis of listericidal activity of peritoneal cells</title><p>Cells were flushed from the peritoneum of mice that had been mock infected or infected with MHV68 for 32 days with ice cold DMEM containing 10% FBS and 2 mM L-Glutamine. 5 × 10<sup>5</sup> cells were plated on glass coverslips in 24 well plates in duplicate wells per timepoint and allowed to adhere overnight. Non-adherent cells were washed away with warm medium, and the remaining cells were infected with 10<sup>5</sup> CFU <italic>Listeria</italic> from a overnight standing culture by spinocculation at 600×<italic>g</italic> for 10 min at room temperature, and then incubated at 37 °C and 5% CO<sub>2</sub>. 50 μg/ml gentamycin was added after 30 min to kill extracellular bacteria. Coverslips were washed in warm PBS prior to hypotonic lysis of the cells in ice cold water to release the bacteria. Serial dilutions were plated on brain heart infusion agar plates, and <italic>Listeria</italic> CFU were counted after overnight growth at 37°C.</p></sec><sec id="s4-6"><title>Generation of bone marrow chimeric mice</title><p>Recipient mice were exposed to 1200 rad of whole body irradiation, and injected intravenously with 10 million whole bone marrow cells from donor mice. Mice were allowed to reconstitute for 8 to 10 weeks before <italic>Listeria</italic> challenge. Mice were bled at 7 weeks post-irradiation to determine percent chimerism. Genomic DNA was isolated from peripheral blood and analyzed by quantitative real-time PCR (qRT-PCR) for the presence of <italic>Rbck1/Hoil1</italic> intron 7 (in control cells; 5′-ATG CTG GAG TAG AGG CTG GA-3′ and 5′-TGA CTG CTG CTT GGA GAG TG-3′), or the neomycin-resistance cassette (in HOIL-1 KO cells; 5′-CAA GAT GGA TTG CAC GCA GG-3′ and 5′-GCA GCC GAT TGT CTG TTG TG-3′). <italic>Rag2</italic> was used as a normalization control (5′-GGG AGG ACA CTC ACT TGC CAG TA-3′ and 5′-AGT CAG GAG TCT CCA TCT CAC TGA-3′).</p></sec><sec id="s4-7"><title><italic>T. gondii</italic> Pru-luc in vivo luciferase imaging</title><p>Imaging was performed as described previously (<xref ref-type="bibr" rid="bib23">Saeij et al., 2005</xref>). Briefly, mice were injected i.p. with 150 mg/kg D-Luciferin (Biosynth AG, Switzerland) and allowed to remain active for 5 min. Animals were subsequently anesthetized with 2% isoflurane for 5 min and then imaged with a Xenogen IVIS 200 machine (Caliper Life Sciences, Hopkinton, MA). Data were analyzed using Living Image software (Caliper Life Sciences).</p></sec><sec id="s4-8"><title>Flow cytometry</title><p>Peritoneal exudate cells were harvested by peritoneal lavage with 10 ml ice cold FACS buffer (PBS supplemented with 2% FBS and 50 U/ml Penicillin and 50 µg/ml Streptomycin). Splenocytes were isolated by filtering through two 100 μm cell strainers into 10 ml ice cold FACS buffer. Residual red blood cells were lysed with Red Blood Cell lysis buffer (Sigma, St Louis, MO), counted and stained for flow cytometry.</p><p>Cells were incubated with FACS buffer plus 1% rat serum, 1% hamster serum and 1% Fc-block for 15 min. Surface staining was performed for 30 min at room temperature. Cells were then washed and fixed with 2% formaldehyde. Cells were analyzed on an LSRII or LSR Fortessa flow cytometer (BD, Franklin Lakes, NJ) and the data were analyzed using FlowJo software (Tree Star, Inc, Ashland, OR). The following antibodies were used: anti-CD3e (clone 145-2C11, Biolegend, San Diego, CA), anti-CD4 (clone RM4-5, BD Pharmingen), anti-CD8 (clone 53-6.7, Biolegend), anti-IgM (clone II/41, BD Pharmingen), anti-CD19 (clone 6D5, Biolegend), anti-NK1.1 (clone PK136, BD Pharmingen), anti-NKp46 (clone 29A1.4, eBioscience, San Diego, CA), anti-Ly6C (clone HK1.4, Biolegend), anti-Ly6G (clone 1A8, Biolgend, anti-CD11b (clone M1/70, BD Pharmingen), anti-F4/80 (clone BM8, Biolegend).</p></sec><sec id="s4-9"><title>Cytokine analysis</title><p>Cytokines in mouse serum and cell supernatants were quantitated using a custom Procarta Immunoassay Kit (Affymetrix, Santa Clara, CA) and analyzed on a Bio-Plex 200 System (BioRad, Hercules, CA) or by ELISA (BD, Franklin Lakes, NJ), respectively, according to the manufacturers’ instructions.</p></sec><sec id="s4-10"><title>Quantitative reverse transcriptase-PCR</title><p>Spleen sections were homogenized, and macrophages were lysed in TRI-Reagent (Sigma), and processed according to the manufacturer's instructions to isolate total RNA. RNA was isolated from peritoneal cells using RNeasy mini kit (Qiagen, Netherlands). RNA samples were treated with Turbo DNA-free DNase (Ambion, Austin, TX) prior to first strand cDNA synthesis with ImProm-II (Promega, Madison, WI) and random hexamer primers. Quantitative PCR was performed on a StepOnePlus machine using Power SYBR Green master mix (Applied Biosystems, Waltham, MA) and primers specific for ribosomal protein S29 (<italic>Rps29</italic>; 5′-AGC AGC TCT ACT GGA GTC ACC-3′ and 5′-AGG TCG CTT AGT CCA ACT TAA TG-3′), <italic>Rbck1/Hoil-1</italic> (5′-ATT CGG CGG AAT GGA GAC GG-3′ and 5′-CTG GTT GGT CCT GGG CTT CG-3′), <italic>Trib3</italic> (5′-CAC ACT GCC ACA AGC ACG GG-3′ and 5′-CAC GCA GGC ATC TTC CAG G-3′), <italic>Tbc1d20</italic> (5′-TGA GGG AGG GCT CCT GAC TG-3′ and 5′-AGC AGC ACT TGC TGG TAG TCC-3′), <italic>Il12b</italic> (5′-GCA CGG CAG CAG AAT AAA TAT GAG-3′ and 5′-TTC AAA GGC TTC ATC TGC AAG TTC-3′), <italic>Tnf</italic> (5′-GGG TGA TCG GTC CCC AAA GG-3′ and 5′- CTG AGT GTG AGG GTC TGG GC-3′), <italic>Il6</italic> (5′-GCC AGA GTC CTT CAG AGA GAT ACA-3′ and 5′-CTT GGT CCT TAG CCA CTC CTT C-3′), <italic>Ifng</italic> (5′-ATG AAC GCT ACA CAC TGC ATC-3′ and 5′-CCA TCC TTT TGC CAG TTC CTC-3′) and <italic>iNos</italic> (<italic>Nos2</italic>) (5′-GTT CTC AGC CCA ACA ATA CAA GA-3′ and 5′-GTG GAC GGG TCG ATG TCA C-3′). Transcript levels were analyzed using the ΔΔC<sub>T</sub> method, with <italic>Rps29</italic> as the reference gene.</p></sec><sec id="s4-11"><title>Histology</title><p>Tissues were fixed in 10% buffered formalin followed by 70% ethanol, paraffin embedded, sectioned and stained with Periodic acid-Schiff (PAS).</p></sec><sec id="s4-12"><title>Mouse blood work</title><p>Alanine aminotransferase and aspartate aminotransferase were measured on a Liasys 330 (AMS Diagnostics, Weston, FL), complete blood counts were measured on a Hemavet 1700 (Drew Scientific, Waterbury, CT), and white blood cell differential counts were performed by Washington University Division of Comparative Medicine Animal Diagnostic Laboratory staff.</p></sec><sec id="s4-13"><title>Statistical analyses</title><p>Statistical significance was determined using GraphPad Prism software. The specific tests performed are noted in the figure legends.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to acknowledge D Kreamalmeyer, JS Lee, Q Wang, CY Liu, Q Lu, M T Baldridge, T J Nice, the Washington University Department of Comparative Medicine Animal Diagnostic Laboratory and the Digestive Diseases Research Core Center for technical assistance, and ER Unanue for critical discussions and reading of the manuscript. We would like to thank Vishva Dixit and Genentec (San Francisco, CA) for providing the Caspase-1/Caspase-11 mutant mice containing a Caspase-11 transgene. HWV was funded by the Crohn's and Colitis Foundation Genetics Initiative grant #274415, Broad Foundation grant #IBD-0357, U19 AI109725 and R01 AI084887. BTE is supported by a Burroughs Wellcome Fund Career Award for Medical Scientists, a Basil O' Connor Starter Scholar Research Award from the March of Dimes Foundation, and a grant from the Edward Mallinckrodt Jr Foundation. JLC was funded by NIAID grant #5P01AI061093, NIH grant #8UL1TR000043 from the National Center for Research Resources and the National Center for Advancing Sciences, and the St. Giles Foundation. LDS was funded by grant # AI036629. JAC was funded by grant #AI062832. CLS is supported by a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation. JMK is supported by a National Science Foundation Graduate Research Fellowship DGE-1143954 and the NIGMS Cell and Molecular Biology Training Grant GM007067.</p></ack><sec sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>DAM, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>TAR, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con3"><p>JMK, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con4"><p>LAW, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>CS, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con6"><p>XZ, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con7"><p>AK, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con8"><p>ED, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con9"><p>JAC, Conception and design, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con10"><p>BTE, Conception and design, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con11"><p>LDS, Conception and design, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con12"><p>CLS, Conception and design, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con13"><p>BB, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con14"><p>EL, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con15"><p>AI, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con16"><p>CP, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con17"><p>MC, Conception and design</p></fn><fn fn-type="con" id="con18"><p>J-LC, Conception and design, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con19"><p>KI, Conception and design, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con20"><p>HWV, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were housed and bred at Washington University in Saint Louis in specific pathogen-free conditions in accordance with Federal and University guidelines and protocols were approved by the Animal Studies Committee of Washington University under protocol number 20140244.</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>E</given-names></name><name><surname>Mandal</surname><given-names>P</given-names></name><name><surname>Speck</surname><given-names>SH</given-names></name></person-group><year>2011</year><article-title>Pathogenesis and host control of gammaherpesviruses: lessons from the mouse</article-title><source>Annual Review of Immunology</source><volume>29</volume><fpage>351</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-072710-081639</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>ES</given-names></name><name><surname>White</surname><given-names>DW</given-names></name><name><surname>Cathelyn</surname><given-names>JS</given-names></name><name><surname>Brett-McClellan</surname><given-names>KA</given-names></name><name><surname>Engle</surname><given-names>M</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Miller</surname><given-names>VL</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group><year>2007</year><article-title>Herpesvirus latency confers symbiotic protection from bacterial infection</article-title><source>Nature</source><volume>447</volume><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1038/nature05762</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Hand</surname><given-names>TW</given-names></name></person-group><year>2014</year><article-title>Role of the Microbiota in Immunity and Inflammation</article-title><source>Cell</source><volume>157</volume><fpage>121</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.011</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boisson</surname><given-names>B</given-names></name><name><surname>Laplantine</surname><given-names>E</given-names></name><name><surname>Prando</surname><given-names>C</given-names></name><name><surname>Giliani</surname><given-names>S</given-names></name><name><surname>Israelsson</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Abhyankar</surname><given-names>A</given-names></name><name><surname>Israel</surname><given-names>L</given-names></name><name><surname>Trevejo-Nunez</surname><given-names>G</given-names></name><name><surname>Bogunovic</surname><given-names>D</given-names></name><name><surname>Cepika</surname><given-names>AM</given-names></name><name><surname>Macduff</surname><given-names>D</given-names></name><name><surname>Chrabieh</surname><given-names>M</given-names></name><name><surname>Hubeau</surname><given-names>M</given-names></name><name><surname>Bajolle</surname><given-names>F</given-names></name><name><surname>Debré</surname><given-names>M</given-names></name><name><surname>Mazzolari</surname><given-names>E</given-names></name><name><surname>Vairo</surname><given-names>D</given-names></name><name><surname>Agou</surname><given-names>F</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Bossuyt</surname><given-names>X</given-names></name><name><surname>Rambaud</surname><given-names>C</given-names></name><name><surname>Facchetti</surname><given-names>F</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Quartier</surname><given-names>P</given-names></name><name><surname>Fournet</surname><given-names>JC</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>Notarangelo</surname><given-names>LD</given-names></name><name><surname>Puel</surname><given-names>A</given-names></name><name><surname>Israel</surname><given-names>A</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name></person-group><year>2012</year><article-title>Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency</article-title><source>Nature Immunology</source><volume>13</volume><fpage>1178</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1038/ni.2457</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Quintana-Murci</surname><given-names>L</given-names></name></person-group><year>2013</year><article-title>Immunology taught by human genetics</article-title><source>Cold Spring Harbor Symposia on Quantitative Biology</source><volume>78</volume><fpage>157</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1101/sqb.2013.78.019968</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damgaard</surname><given-names>RB</given-names></name><name><surname>Nachbur</surname><given-names>U</given-names></name><name><surname>Yabal</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>WW</given-names></name><name><surname>Fiil</surname><given-names>BK</given-names></name><name><surname>Kastirr</surname><given-names>M</given-names></name><name><surname>Rieser</surname><given-names>E</given-names></name><name><surname>Rickard</surname><given-names>JA</given-names></name><name><surname>Bankovacki</surname><given-names>A</given-names></name><name><surname>Peschel</surname><given-names>C</given-names></name><name><surname>Ruland</surname><given-names>J</given-names></name><name><surname>Bekker-Jensen</surname><given-names>S</given-names></name><name><surname>Mailand</surname><given-names>N</given-names></name><name><surname>Kaufmann</surname><given-names>T</given-names></name><name><surname>Strasser</surname><given-names>A</given-names></name><name><surname>Walczak</surname><given-names>H</given-names></name><name><surname>Silke</surname><given-names>J</given-names></name><name><surname>Jost</surname><given-names>PJ</given-names></name><name><surname>Gyrd-Hansen</surname><given-names>M</given-names></name></person-group><year>2012</year><article-title>The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity</article-title><source>Molecular Cell</source><volume>46</volume><fpage>746</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.04.014</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelson</surname><given-names>BT</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><year>2002</year><article-title>MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity</article-title><source>The Journal of Immunology</source><volume>169</volume><fpage>3869</fpage><lpage>3875</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.7.3869</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>B</given-names></name><name><surname>Cordier</surname><given-names>SM</given-names></name><name><surname>Schmukle</surname><given-names>AC</given-names></name><name><surname>Emmerich</surname><given-names>CH</given-names></name><name><surname>Rieser</surname><given-names>E</given-names></name><name><surname>Haas</surname><given-names>TL</given-names></name><name><surname>Webb</surname><given-names>AI</given-names></name><name><surname>Rickard</surname><given-names>JA</given-names></name><name><surname>Anderton</surname><given-names>H</given-names></name><name><surname>Wong</surname><given-names>WW</given-names></name><name><surname>Nachbur</surname><given-names>U</given-names></name><name><surname>Gangoda</surname><given-names>L</given-names></name><name><surname>Warnken</surname><given-names>U</given-names></name><name><surname>Purcell</surname><given-names>AW</given-names></name><name><surname>Silke</surname><given-names>J</given-names></name><name><surname>walczak</surname><given-names>H</given-names></name></person-group><year>2011</year><article-title>Linear ubiquitination prevents inflammation and regulates immune signalling</article-title><source>Nature</source><volume>471</volume><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1038/nature09816</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>TL</given-names></name><name><surname>Emmerich</surname><given-names>CH</given-names></name><name><surname>Gerlach</surname><given-names>B</given-names></name><name><surname>Schmukle</surname><given-names>AC</given-names></name><name><surname>Cordier</surname><given-names>SM</given-names></name><name><surname>Rieser</surname><given-names>E</given-names></name><name><surname>Feltham</surname><given-names>R</given-names></name><name><surname>Vince</surname><given-names>J</given-names></name><name><surname>Warnken</surname><given-names>U</given-names></name><name><surname>Wenger</surname><given-names>T</given-names></name><name><surname>Koschny</surname><given-names>R</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>Silke</surname><given-names>J</given-names></name><name><surname>Walczak</surname><given-names>H</given-names></name></person-group><year>2009</year><article-title>Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction</article-title><source>Molecular Cell</source><volume>36</volume><fpage>831</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.10.013</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>A</given-names></name><name><surname>Rachinel</surname><given-names>N</given-names></name><name><surname>Quddus</surname><given-names>MR</given-names></name><name><surname>Haque</surname><given-names>S</given-names></name><name><surname>Kasper</surname><given-names>LH</given-names></name><name><surname>Usherwood</surname><given-names>E</given-names></name></person-group><year>2004</year><article-title>Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection</article-title><source>Clinical and Experimental Immunology</source><volume>138</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02652.x</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HogenEsch</surname><given-names>H</given-names></name><name><surname>Janke</surname><given-names>S</given-names></name><name><surname>Boggess</surname><given-names>D</given-names></name><name><surname>Sundberg</surname><given-names>JP</given-names></name></person-group><year>1999</year><article-title>Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice</article-title><source>The Journal of Immunology</source><volume>162</volume><fpage>3890</fpage><lpage>3896</lpage></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hostager</surname><given-names>BS</given-names></name><name><surname>Kashiwada</surname><given-names>M</given-names></name><name><surname>Colgan</surname><given-names>JD</given-names></name><name><surname>Rothman</surname><given-names>PB</given-names></name></person-group><year>2011</year><article-title>HOIL-1L interacting protein (HOIP) is essential for CD40 signaling</article-title><source>PLOS ONE</source><volume>6</volume><fpage>e23061</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0023061</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>S</given-names></name><name><surname>Maloney</surname><given-names>NS</given-names></name><name><surname>Bruinsma</surname><given-names>MW</given-names></name><name><surname>Goel</surname><given-names>G</given-names></name><name><surname>Duan</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Shrestha</surname><given-names>B</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Dani</surname><given-names>A</given-names></name><name><surname>Sosnovtsev</surname><given-names>SV</given-names></name><name><surname>Green</surname><given-names>KY</given-names></name><name><surname>Lopez-Otin</surname><given-names>C</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Thackray</surname><given-names>LB</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group><year>2012</year><article-title>Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma</article-title><source>Cell Host &amp; Microbe</source><volume>11</volume><fpage>397</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.03.002</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>F</given-names></name><name><surname>Deribe</surname><given-names>YL</given-names></name><name><surname>Skanland</surname><given-names>SS</given-names></name><name><surname>Stieglitz</surname><given-names>B</given-names></name><name><surname>Grabbe</surname><given-names>C</given-names></name><name><surname>Franz-Wachtel</surname><given-names>M</given-names></name><name><surname>van Wijk</surname><given-names>SJ</given-names></name><name><surname>Goswami</surname><given-names>P</given-names></name><name><surname>Nagy</surname><given-names>V</given-names></name><name><surname>Terzic</surname><given-names>J</given-names></name><name><surname>Tokunaga</surname><given-names>F</given-names></name><name><surname>Androulidaki</surname><given-names>A</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Pasparakis</surname><given-names>M</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><name><surname>Sundberg</surname><given-names>JP</given-names></name><name><surname>Schaefer</surname><given-names>L</given-names></name><name><surname>Rittinger</surname><given-names>K</given-names></name><name><surname>Macek</surname><given-names>B</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name></person-group><year>2011</year><article-title>SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis</article-title><source>Nature</source><volume>471</volume><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1038/nature09814</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayagaki</surname><given-names>N</given-names></name><name><surname>Wong</surname><given-names>MT</given-names></name><name><surname>Stowe</surname><given-names>IB</given-names></name><name><surname>Ramani</surname><given-names>SR</given-names></name><name><surname>Gonzalez</surname><given-names>LC</given-names></name><name><surname>Akashi-Takamura</surname><given-names>S</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Muszynski</surname><given-names>A</given-names></name><name><surname>Forsberg</surname><given-names>LS</given-names></name><name><surname>Carlson</surname><given-names>RW</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year>2013</year><article-title>Noncanonical inflammasome activation by intracellular LPS independent of TLR4</article-title><source>Science</source><volume>341</volume><fpage>1246</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1126/science.1240248</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopf</surname><given-names>M</given-names></name><name><surname>Baumann</surname><given-names>H</given-names></name><name><surname>Freer</surname><given-names>G</given-names></name><name><surname>Freudenberg</surname><given-names>M</given-names></name><name><surname>Lamers</surname><given-names>M</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Zinkernagel</surname><given-names>R</given-names></name><name><surname>Bluethmann</surname><given-names>H</given-names></name><name><surname>Kohler</surname><given-names>G</given-names></name></person-group><year>1994</year><article-title>Impaired immune and acute-phase responses in interleukin-6-deficient mice</article-title><source>Nature</source><volume>368</volume><fpage>339</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/368339a0</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name><name><surname>Garber</surname><given-names>M</given-names></name><name><surname>Zuk</surname><given-names>O</given-names></name><name><surname>Lin</surname><given-names>MF</given-names></name><name><surname>Parker</surname><given-names>BJ</given-names></name><name><surname>Washietl</surname><given-names>S</given-names></name><name><surname>Kheradpour</surname><given-names>P</given-names></name><name><surname>Ernst</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>G</given-names></name><name><surname>Mauceli</surname><given-names>E</given-names></name><name><surname>Ward</surname><given-names>LD</given-names></name><name><surname>Lowe</surname><given-names>CB</given-names></name><name><surname>Holloway</surname><given-names>AK</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Gnerre</surname><given-names>S</given-names></name><name><surname>Alfoldi</surname><given-names>J</given-names></name><name><surname>Beal</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Cuff</surname><given-names>J</given-names></name><name><surname>Di Palma</surname><given-names>F</given-names></name><name><surname>Fitzgerald</surname><given-names>S</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Hubisz</surname><given-names>MJ</given-names></name><name><surname>Jaffe</surname><given-names>DB</given-names></name><name><surname>Jungreis</surname><given-names>I</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Kostka</surname><given-names>D</given-names></name><name><surname>Lara</surname><given-names>M</given-names></name><name><surname>Martins</surname><given-names>AL</given-names></name><name><surname>Massingham</surname><given-names>T</given-names></name><name><surname>Moltke</surname><given-names>I</given-names></name><name><surname>Raney</surname><given-names>BJ</given-names></name><name><surname>Rasmussen</surname><given-names>MD</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name><name><surname>Vilella</surname><given-names>AJ</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Zody</surname><given-names>MC</given-names></name><collab>Broad Institute Sequencing Platform and whole Genome Assembly team</collab><name><surname>Baldwin</surname><given-names>J</given-names></name><name><surname>Bloom</surname><given-names>T</given-names></name><name><surname>Chin</surname><given-names>CW</given-names></name><name><surname>Heiman</surname><given-names>D</given-names></name><name><surname>Nicol</surname><given-names>R</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>S</given-names></name><name><surname>Wilkinson</surname><given-names>J</given-names></name><name><surname>Worley</surname><given-names>KC</given-names></name><name><surname>Kovar</surname><given-names>CL</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><collab>Baylor College of Medicine Human Genome Sequencing Center Sequencing Team</collab><name><surname>Cree</surname><given-names>A</given-names></name><name><surname>Dihn</surname><given-names>HH</given-names></name><name><surname>Fowler</surname><given-names>G</given-names></name><name><surname>Jhangiani</surname><given-names>S</given-names></name><name><surname>Joshi</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>LR</given-names></name><name><surname>Nazareth</surname><given-names>LV</given-names></name><name><surname>Okwuonu G</surname></name><name><surname>Santibanez</surname><given-names>J</given-names></name><name><surname>Warren</surname><given-names>WC</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><collab>Genome Institute at Washington University</collab><name><surname>Delehaunty</surname><given-names>K</given-names></name><name><surname>Dooling</surname><given-names>D</given-names></name><name><surname>Fronik</surname><given-names>C</given-names></name><name><surname>Fulton</surname><given-names>L</given-names></name><name><surname>Fulton</surname><given-names>B</given-names></name><name><surname>Graves</surname><given-names>T</given-names></name><name><surname>Minx</surname><given-names>P</given-names></name><name><surname>Sodergren</surname><given-names>E</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Margulies</surname><given-names>EH</given-names></name><name><surname>Herrero</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Siepel</surname><given-names>A</given-names></name><name><surname>Goldman</surname><given-names>N</given-names></name><name><surname>Pollard</surname><given-names>KS</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name></person-group><year>2011</year><article-title>A high-resolution map of human evolutionary constraint using 29 mammals</article-title><source>Nature</source><volume>478</volume><fpage>476</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1038/nature10530</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorman</surname><given-names>NJ</given-names></name><name><surname>Willer</surname><given-names>DO</given-names></name><name><surname>Speck</surname><given-names>SH</given-names></name></person-group><year>2003</year><article-title>The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency</article-title><source>Journal of Virology</source><volume>77</volume><fpage>10295</fpage><lpage>10303</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.19.10295-10303.2003</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>Y</given-names></name><name><surname>Mcguffie</surname><given-names>BA</given-names></name><name><surname>Anderson</surname><given-names>VE</given-names></name><name><surname>Weinberg</surname><given-names>JB</given-names></name></person-group><year>2008</year><article-title>Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis</article-title><source>Virology</source><volume>380</volume><fpage>182</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2008.07.031</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Schoser</surname><given-names>B</given-names></name><name><surname>Laforet</surname><given-names>P</given-names></name><name><surname>Kalev</surname><given-names>O</given-names></name><name><surname>Lindberg</surname><given-names>C</given-names></name><name><surname>Romero</surname><given-names>NB</given-names></name><name><surname>Dávila López</surname><given-names>M</given-names></name><name><surname>Akman</surname><given-names>HO</given-names></name><name><surname>Wahbi</surname><given-names>K</given-names></name><name><surname>Iglseder</surname><given-names>S</given-names></name><name><surname>Eggers</surname><given-names>C</given-names></name><name><surname>Engel</surname><given-names>AG</given-names></name><name><surname>Dimauro</surname><given-names>S</given-names></name><name><surname>Oldfors</surname><given-names>A</given-names></name></person-group><year>2013</year><article-title>Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1</article-title><source>Annals of Neurology</source><volume>74</volume><fpage>914</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1002/ana.23963</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana-Murci</surname><given-names>L</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name></person-group><year>2013</year><article-title>Population genetic tools for dissecting innate immunity in humans</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>280</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1038/nri3421</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>MA</given-names></name><name><surname>Bowman</surname><given-names>JW</given-names></name><name><surname>Fujita</surname><given-names>H</given-names></name><name><surname>Orazio</surname><given-names>N</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Amatya</surname><given-names>R</given-names></name><name><surname>Kelly</surname><given-names>TJ</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><name><surname>Ting</surname><given-names>J</given-names></name><name><surname>Jung</surname><given-names>JU</given-names></name></person-group><year>2014</year><article-title>The linear utiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>1333</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1084/jem.20132486</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeij</surname><given-names>JP</given-names></name><name><surname>Boyle</surname><given-names>JP</given-names></name><name><surname>Grigg</surname><given-names>ME</given-names></name><name><surname>Arrizabalaga</surname><given-names>G</given-names></name><name><surname>Boothroyd</surname><given-names>JC</given-names></name></person-group><year>2005</year><article-title>Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains</article-title><source>Infection and Immunity</source><volume>73</volume><fpage>695</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.2.695-702.2005</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarawar</surname><given-names>SR</given-names></name><name><surname>Brooks</surname><given-names>JW</given-names></name><name><surname>Cardin</surname><given-names>RD</given-names></name><name><surname>Mehrpooya</surname><given-names>M</given-names></name><name><surname>Doherty</surname><given-names>PC</given-names></name></person-group><year>1998</year><article-title>Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6- deficient mice</article-title><source>Virology</source><volume>249</volume><fpage>359</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1006/viro.1998.9309</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Sano</surname><given-names>S</given-names></name><name><surname>Nakahara</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>S</given-names></name><name><surname>Kometani</surname><given-names>K</given-names></name><name><surname>Aiba</surname><given-names>Y</given-names></name><name><surname>Sakamoto</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Kurosaki</surname><given-names>T</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name></person-group><year>2013</year><article-title>Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2463</fpage><lpage>2476</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.184</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>JD</given-names></name><name><surname>Pereyre</surname><given-names>S</given-names></name><name><surname>Archer</surname><given-names>KA</given-names></name><name><surname>Burke</surname><given-names>TP</given-names></name><name><surname>Hanson</surname><given-names>B</given-names></name><name><surname>Lauer</surname><given-names>P</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group><year>2011</year><article-title>Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>108</volume><fpage>12419</fpage><lpage>12424</lpage><pub-id pub-id-type="doi">10.1073/pnas.1019041108</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>RE</given-names></name><name><surname>Hasham</surname><given-names>MG</given-names></name><name><surname>Cox</surname><given-names>GA</given-names></name><name><surname>Shultz</surname><given-names>LD</given-names></name><name><surname>Hogenesch</surname><given-names>H</given-names></name><name><surname>Roopenian</surname><given-names>DC</given-names></name><name><surname>Sundberg</surname><given-names>JP</given-names></name></person-group><year>2007</year><article-title>Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis</article-title><source>Genes and Immunity</source><volume>8</volume><fpage>416</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6364403</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speck</surname><given-names>SH</given-names></name><name><surname>Ganem</surname><given-names>D</given-names></name></person-group><year>2010</year><article-title>Viral latency and its regulation: lessons from the gamma-herpesviruses</article-title><source>Cell Host &amp; Microbe</source><volume>8</volume><fpage>100</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2010.06.014</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeshita</surname><given-names>S</given-names></name><name><surname>Kaji</surname><given-names>K</given-names></name><name><surname>Kudo</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts</article-title><source>Journal of Bone and Mineral Research</source><volume>15</volume><fpage>1477</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1359/jbmr.2000.15.8.1477</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>YY</given-names></name><name><surname>Diao</surname><given-names>FC</given-names></name><name><surname>Wang</surname><given-names>RP</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>DY</given-names></name><name><surname>Zhai</surname><given-names>ZH</given-names></name><name><surname>Shu</surname><given-names>HB</given-names></name></person-group><year>2007</year><article-title>RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation</article-title><source>The Journal of Biological Chemistry</source><volume>282</volume><fpage>16776</fpage><lpage>16782</lpage><pub-id pub-id-type="doi">10.1074/jbc.M701913200</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>F</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name></person-group><year>2012</year><article-title>LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses</article-title><source>Microbes and Infection</source><volume>14</volume><fpage>563</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2012.01.011</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>F</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Nakahara</surname><given-names>M</given-names></name><name><surname>Saeki</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Sakata</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name></person-group><year>2011</year><article-title>SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex</article-title><source>Nature</source><volume>471</volume><fpage>633</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nature09815</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>F</given-names></name><name><surname>Nishimasu</surname><given-names>H</given-names></name><name><surname>Ishitani</surname><given-names>R</given-names></name><name><surname>Goto</surname><given-names>E</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Mio</surname><given-names>K</given-names></name><name><surname>Kamei</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>A</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><name><surname>Nureki</surname><given-names>O</given-names></name></person-group><year>2012</year><article-title>Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-kappaB regulation</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>3856</fpage><lpage>3870</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.241</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>F</given-names></name><name><surname>Sakata</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>Y</given-names></name><name><surname>Satomi</surname><given-names>Y</given-names></name><name><surname>Kirisako</surname><given-names>T</given-names></name><name><surname>Kamei</surname><given-names>K</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>S</given-names></name><name><surname>Yamaoka</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Takao</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name></person-group><year>2009</year><article-title>Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation</article-title><source>Nature Cell Biology</source><volume>11</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1038/ncb1821</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>NM</given-names></name><name><surname>Tsutsui</surname><given-names>H</given-names></name><name><surname>Seki</surname><given-names>E</given-names></name><name><surname>Kuida</surname><given-names>K</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><year>2004</year><article-title>Roles of caspase-1 in Listeria infection in mice</article-title><source>International Immunology</source><volume>16</volume><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxh041</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><year>1997</year><article-title>Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance</article-title><source>Current Opinion in Immunology</source><volume>9</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S0952-7915(97)80156-2</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhelst</surname><given-names>K</given-names></name><name><surname>Carpentier</surname><given-names>I</given-names></name><name><surname>Kreike</surname><given-names>M</given-names></name><name><surname>Meloni</surname><given-names>L</given-names></name><name><surname>Verstrepen</surname><given-names>L</given-names></name><name><surname>Kensche</surname><given-names>T</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name><name><surname>Beyaert</surname><given-names>R</given-names></name></person-group><year>2012</year><article-title>A20 inhibits LUBAC-mediated NF-kappaB activation by binding linear polyubiquitin chains via its zinc finger 7</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>3845</fpage><lpage>3855</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.240</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group><year>2014</year><article-title>The virome in mammalian physiology and disease</article-title><source>Cell</source><volume>157</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.02.032</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><year>2011</year><article-title>Metagenomics and personalized medicine</article-title><source>Cell</source><volume>147</volume><fpage>44</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.09.009</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year>2009</year><article-title>Redefining chronic viral infection</article-title><source>Cell</source><volume>138</volume><fpage>30</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.06.036</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Bradfield</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Toskala</surname><given-names>E</given-names></name><name><surname>Otieno</surname><given-names>FG</given-names></name><name><surname>Hou</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>K</given-names></name><name><surname>Cardinale</surname><given-names>C</given-names></name><name><surname>Lyon</surname><given-names>GJ</given-names></name><name><surname>Golhar</surname><given-names>R</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name></person-group><year>2013</year><article-title>Whole-genome DNA/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement</article-title><source>Genome Medicine</source><volume>5</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.1186/gm471</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weck</surname><given-names>KE</given-names></name><name><surname>Barkon</surname><given-names>ML</given-names></name><name><surname>Yoo</surname><given-names>LI</given-names></name><name><surname>Speck</surname><given-names>SH</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names><suffix>IV</suffix></name></person-group><year>1996</year><article-title>Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68</article-title><source>Journal of Virology</source><volume>70</volume><fpage>6775</fpage><lpage>6780</lpage></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weck</surname><given-names>KE</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Speck</surname><given-names>SH</given-names></name></person-group><year>1999</year><article-title>Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells</article-title><source>Journal of Virology</source><volume>73</volume><fpage>3273</fpage><lpage>3283</lpage></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>DW</given-names></name><name><surname>Keppel</surname><given-names>CR</given-names></name><name><surname>Schneider</surname><given-names>SE</given-names></name><name><surname>Reese</surname><given-names>TA</given-names></name><name><surname>Coder</surname><given-names>J</given-names></name><name><surname>Payton</surname><given-names>JE</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Fehniger</surname><given-names>TA</given-names></name></person-group><year>2010</year><article-title>Latent herpesvirus infection arms NK cells</article-title><source>Blood</source><volume>115</volume><fpage>4377</fpage><lpage>4383</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-09-245464</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Schmidt</surname><given-names>RL</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group><year>2012</year><article-title>Early events regulating immunity and pathogenesis during Listeria monocytogenes infection</article-title><source>Trends in Immunology</source><volume>33</volume><fpage>488</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1016/j.it.2012.04.007</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yager</surname><given-names>EJ</given-names></name><name><surname>Szaba</surname><given-names>FM</given-names></name><name><surname>Kummer</surname><given-names>LW</given-names></name><name><surname>Lanzer</surname><given-names>KG</given-names></name><name><surname>Burkum</surname><given-names>CE</given-names></name><name><surname>Smiley</surname><given-names>ST</given-names></name><name><surname>Blackman</surname><given-names>MA</given-names></name></person-group><year>2009</year><article-title>gamma-Herpesvirus-induced Protection against bacterial infection is transient</article-title><source>Viral Immunology</source><volume>22</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1089/vim.2008.0086</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>DE</given-names></name><name><surname>Schmitz</surname><given-names>F</given-names></name><name><surname>Gold</surname><given-names>ES</given-names></name><name><surname>Diercks</surname><given-names>AH</given-names></name><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Valvo</surname><given-names>JS</given-names></name><name><surname>Niemisto</surname><given-names>A</given-names></name><name><surname>Podolsky</surname><given-names>I</given-names></name><name><surname>Fallen</surname><given-names>SG</given-names></name><name><surname>Suen</surname><given-names>R</given-names></name><name><surname>Stolyar</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>Kennedy</surname><given-names>KA</given-names></name><name><surname>Hamilton</surname><given-names>MK</given-names></name><name><surname>Siggs</surname><given-names>OM</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name><name><surname>Aderem</surname><given-names>A</given-names></name></person-group><year>2011</year><article-title>Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>108</volume><fpage>11536</fpage><lpage>11541</lpage><pub-id pub-id-type="doi">10.1073/pnas.1107577108</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.04494.023</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Goff</surname><given-names>Stephen P</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see <ext-link ext-link-type="uri" xlink:href="http://elifesciences.org/review-process">review process</ext-link>). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.</p></boxed-text><p>Thank you for sending your work entitled “Complementation of genetic immunodeficiency by chronic herpesvirus infection” for consideration at <italic>eLife</italic>. Your article has been favorably evaluated by Stylianos Antonarakis (Senior editor), Stephen Goff (Reviewing editor), and 3 reviewers, one of whom, Bill Sugden, has agreed to reveal his identity.</p><p>The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.</p><p>This paper presents a substantial body of work characterizing the responses to infection of mutant mice with HOIL1 deficiency. We were impressed with the extent of the work. As noted by the reviewers, the selectivity of the effects for some pathogens over others is of interest; and most important is the effect of preinfection with MHV68 on subsequent challenges by other pathogens. We summarize some of the key points of criticism here, before passing on the full detailed comments of the reviewers.</p><p>The first reviewer found the paper difficult to read. I too found it very dense and not as linear in presentation as I thought was possible. The experiments cover diverse situations and the responses depend on diverse cytokine levels that are introduced as the experiments are described; perhaps some overview of the plan would be helpful to have at the start of the results. And similarly a clearer summary of the authors' thinking on the cytokines' levels' roles in the outcome would be helpful.</p><p>In addition, he raises a substantial number of very specific issues that I think need to be addressed. Most cannot be dismissed simply, including issues of significance of some of the findings.</p><p>The second reviewer had two major issues. The first concerns the effects of MHV68 preinfection in a non-barrier mouse. This is raised because the human situation is obviously non-barrier, and human data might be available to provide information in this setting. While the requested human data would be helpful to have, I am less concerned here about the need to perfectly model the human situation, and comfortable that the barrier mouse findings stand as interesting even without that bearing on the human situation.</p><p>His second concern is an apparent discrepancy between the data and the claims (this is referring to data in <xref ref-type="fig" rid="fig5">Figure 5</xref>). This should be directly addressed and clarified.</p><p>The third reviewer was also supportive but felt many of the findings were unsurprising or predicted by previous work. I feel that there is adequate value to presenting data that might have been expected but in fact have not previously been obtained (as he notes, surprisingly so!). He also felt that there was insufficient explanation of mechanism of action. I think helpful here, as noted above, is for the authors to at least present a clearer case of what they think is the mechanism, even if the case is not proven. With the right caveats, this would make the paper's punchline much stronger, or at least clearer.</p><p><italic>Reviewer #1</italic>:</p><p>This is an interesting study that examines the effect of HOIL1 deficiency on infection of mice with several strains of bacteria (<italic>Listeria monocytogenes</italic>, <italic>Citrobacter rodentium</italic>, and <italic>Mycobacterium Tuberculosis</italic>) a parasite (<italic>Toxoplasma gondii)</italic> and a herpesvirus that establishes a latent infection (murine gamma-herpesvirus 68-MHV68). The results show that the HOIL1 mutant mice are much more susceptible to infection with <italic>Listeria monocytogenes</italic>, <italic>Citrobacter rodentium</italic>, and <italic>Toxoplasma gondii</italic> than wild type mice, but have comparable susceptibility to <italic>Mycobacterium Tuberculosis</italic> and MHV68. Moreover, prior infection of HOIL1 mutant mice with MHV68 reduces their susceptibility to <italic>Listeria</italic> such that it is now comparable to wild type. Latent infection of IL6 mutant mice with MHV68 also reduces their susceptibility to <italic>Listeria</italic> infection.</p><p>The importance of this paper is that it highlights the increasing appreciation that prior viral infection (or bacterial infections) may greatly influence the outcome of subsequent infections and establishment of a hyperinflammatory environment, particularly in the context of immunodeficiency.</p><p>This is a difficult paper to read, as the differential experimental conditions are not clearly delineated in the text. For example, the measurement of cytokine proteins in serum is interspersed with measurement of transcripts, and it is not always evident in the text what is being measured. Likewise, some infections are in vivo, while others are in bone-marrow-derived macrophages. There is also use of <italic>Rag</italic><sup><italic>-/-</italic></sup> mice as the background for HOIL1 mutation interspersed with use of the wild type background.</p><p>The major criticism is that, mechanistically, it is not clear why the HOIL1 animals are more susceptible to some infections but not others. The assumption is that it is relative level of induced cytokines, but this is never directly shown. Although it is stated that the <italic>Mycobacterium Tuberculosis</italic> and MHV68 infections established a hyper-inflammatory phenotype in HOIL1 mutant animals with significant induction of TNFα, IL6, IL12p40, and IFNγ, there is also significant induction of the inflammatory cytokines in wild type mice, albeit to a lower level. Increased expression of inflammatory cytokines is also observed in <italic>Listeria</italic> infected HOIL1 mutant mice, although in this case the levels are lower than those in wild type mice. It is important to note that in some cases the data may be statistically significant, but the differences are marginal.</p><p>Specific comments:</p><p>1) <xref ref-type="fig" rid="fig2s2">Figure 2–figure supplement 2</xref> shows that immunized HOIL1 mutant mice are resistant to high dose secondary of <italic>Listeria</italic>. The data are only shown for day 3. Is this resistance maintained at the same level at later times?</p><p>2) It is important in the text to differentiate between small, and likely insignificant differences, versus larger ones. For example, in <xref ref-type="fig" rid="fig3">Figure 3</xref>: production of TNFα by HOIL1 mutant mice macrophages is only 2-fold lower than wild type mice infected with <italic>Listeria</italic> while there are greater differences in production of IL-6 and IL12p40.</p><p>3) <xref ref-type="fig" rid="fig3s1">Figure 3–figure supplement 1</xref>: what is the point of this figure? It appears that application of IFNγ has same effect on macrophages in both wild type and HOIL1 mutant, as the wild type do not kill <italic>Listeria</italic> in the absence of IFNγ.</p><p>4) <xref ref-type="fig" rid="fig3s2">Figure 3–figure supplement 2</xref>: it should be stated in text that there is no difference in IL12p40. Also the text should state clearly why the <italic>Rag</italic><sup><italic>-/-</italic></sup> mouse background is used in <xref ref-type="fig" rid="fig3s2">Figure 3–figure supplement 2</xref> and <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</p><p>5) <xref ref-type="fig" rid="fig3s3">Figure 3–figure supplement 3</xref> only shows data for <italic>Rag</italic><sup><italic>+/+</italic></sup> mice. Since the <italic>Rag</italic><sup><italic>-/-</italic></sup> mice are also used, the data for non B and non T cells (e.g. macrophages, neutrophils and NK cells) should also be shown for the HOIL1 mutant mice on this background.</p><p>6) <xref ref-type="fig" rid="fig3">Figure 3C</xref>: it should be noted that the IL12p40 difference is only seen at one time point.</p><p>7) In the Results section, it is stated that fewer NK cells and neutrophils at 6 hours correlated with decreased expression of cytokine and IFNγ mRNA. However, there is no difference in the number of NK and neutrophils at 12 h and differences in cytokine and IFNγ mRNA are still present.</p><p>8) <xref ref-type="fig" rid="fig4">Figure 4</xref>: the impairment of reactivation of MHV68 is quite modest (∼2- fold) and it is not “very significant”, as stated in the Results section. Also the “enhanced control of MHV68 replication” in the HOIL1 mutant mice as measured by lower titers is only seen at two of the time points (<xref ref-type="fig" rid="fig4s1">Figure 4–figure supplement 1</xref>).</p><p>9) <xref ref-type="fig" rid="fig4">Figure 4C</xref>: given MHV68 infected wt mouse outlier, the data do not appear to be significant for TNFα.</p><p>10) The legend for <xref ref-type="fig" rid="fig4">Figure 4E</xref> is incorrect. It states that it is the same as 4D. However, from the text in the Results section, this appears to show the data for the mice infected with tuberculosis. What day of the infection is shown?</p><p>11) <xref ref-type="fig" rid="fig5">Figure 5</xref>: it should be clearly stated in the text that the MHV68 latency provided enhanced resistance to <italic>Listeria</italic> infection not only for the HOIL1 mutant and IL6 mutant mice, but also for the wild type mice. Also, from the data shown, one cannot state that the IL6 mutant mice had increased sensitivity to <italic>Listeria</italic> infection, as both the mutant and wild type mice showed the same survival curve due to the large inoculum of <italic>Listeria</italic> that is used.</p><p><italic>Reviewer #2</italic>:</p><p>In this manuscript MacDuff et al. determine that barrier-raised <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice are more susceptible to certain pathogens such as <italic>L. monocytogenes</italic>, <italic>T. gondii</italic> and <italic>C. rodentium</italic> than wild type animals. They find a correlated decrease in the levels of inflammatory cytokines such as IL-6 and TNFα. The authors go on to infect the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice with either MHV68 or <italic>M. tuberculosis</italic> and find that infection with either pathogen increases resistance to subsequent challenges with the other pathogens. They hypothesize that infection with MHV68 modifies the immune response of the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice and that this phenomenon is mirrored in human patients with defective Hoil-1.</p><p>The authors present some potentially exciting findings. However, we find two substantive issues need to be addressed to support and clarify them.</p><p>1) The authors show that infection with MHV68 strengthens the immune response of the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice to subsequent infection with other pathogens. It is essential to know what happens to non-barrier-raised subjects as human patients with Hoil-1 deficiencies are continuously exposed to pathogens. In this context the authors could, for example, look at the high-throughput sequencing data available for human Hoil-1 patients and determine if there are correlations between clinical symptoms and presence/absence of specific pathogens in those samples.</p><p>2) There exists a dissonance in the authors' proposal as to how infection with MHV68 or <italic>M. tuberculosis</italic> protects the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice from subsequent pathogen challenges. While in the Discussion section the authors write “MHV68 latency was associated with increased basal levels of TNFα, IL-6, IL-12 and IFNγ…”, <xref ref-type="fig" rid="fig5">Figure 5C</xref> indicates that TNFα, IL-6 and IL-12 levels did not rise with MHV68 infection. The authors need both to address this discrepancy and explain how IFNγ levels are increasing in the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice when they are infected with MHV68.</p><p><italic>Reviewer #3</italic>:</p><p>MacDuff and colleagues use a <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mouse model to examine the role of Hoil-1 in host-defense against bacterial, parasitic, and viral infections. Although the Hoil-1 knockout has been available since 2009, surprisingly, it has not yet been characterized with infection models in detail. By comparison, biallelic loss-of-expression and loss-of-function HOIL-1L deficiencies in humans causes a fatal disorder characterized by chronic auto-inflammation, invasive bacterial infections, and muscular amylopectinosis. Likewise, mice deficient in the LUBAC component sharpin have immune-deficiency. MacDuff et al. report that in barrier-housed mice, amylopectin-like deposits occur, but hyper-inflammation does not. Nonetheless, they are immunodeficient, and are highly susceptible to challenge with <italic>listeria</italic>, <italic>toxoplasma</italic> or <italic>citrobacter</italic>.</p><p>The authors show that Hoil-1 expression in bone-marrow-derived cells is important for protection from bacterial challenge, and for cytokine production. <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice survive at least 3 months of challenge with γ-68 herpesvirus (IP or intranasal), with similar levels of intraperitoneal pool of latent virus. By contrast, they observed that MHV68 reactivation from latently-infected peritoneal cells was impaired by <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> deficiency. Challenge with wildtype MHV68 or <italic>mycobacterium tuberculosis</italic> leads to enhanced production of IL-6, IL-12 and IFNγ in Hoil-1 deficient mice, and also higher levels of TNFα in MTB- treated Hoil-1 deficient mice. Mice infected with MHV68 for 28 days are protected from IP challenge with <italic>listeria</italic>, while MHV68orf73.stop, which does not establish latency, does not protect Hoil-1 knockout mice from <italic>listeria</italic> challenge.</p><p>A strength of the manuscript is that it raises many interesting issues, and highlights the role of LUBAC and inflammation in the host-response to infection. However, many of the results presented are incremental advances that are largely expected from the current literature. For instance, based on the phenotype of humans with Hoil-1 deficiency, it is not surprising that mice are highly susceptible to bacterial challenge (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Likewise, although it is interesting that Hoil-1 expression in hematopoietic cells and even in the granulocyte lineage is important for control of <italic>listeria</italic>, it is not a particularly surprising result (<xref ref-type="fig" rid="fig2">Figure 2</xref>). That cytokine production is impaired in Hoil-1 knockouts in response to <italic>listeria</italic> is also a largely expected result (<xref ref-type="fig" rid="fig3">Figure 3</xref>). It is however interesting that Hoil-1 deficiency has protective effects on MHV68 infection and tuberculosis. While we are shown modest decreases in MTB loads in lung and spleen in Hoil knockouts, we are not shown whether MHV68 viral load is affected by Hoil-1 deficiency, but rather that similar levels of latently infected cells are present in the peritoneum, that MHV68 reactivates less efficiently with Hoil-1 deficiency, and that MHV68 results in increased pro-inflammatory cytokine production with hoil deficiency (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>Perhaps because of this cytokine production that exists 28 days after viral inoculation, Hoil-1 mice are protected from listeriosis. While the results are interesting, a shortcoming of the paper is the lack of novel mechanistic insights. What is the intrinsic mechanism of how latent infection with γ68 protects mice from subsequent challenge with <italic>listeria</italic>? Is it a phenomenon that exists during acute herpesvirus infections? By analogy with human infectious mononucleosis, MHV68-infected mice are likely immune-stimulated by acute herpes virus infections at 28 days post-infection. Does protection from listeriosis persist at later timepoints following MHV68 infection (the situation in most humans with asymptomatic/chronic herpes virus infections), or is it merely a transient phenomenon of acute infection? Since Hoil-1 knockout mice survive for at least 3 months after MHV68 infection, repeating the experiments at that timepoint would add something to the study.</p><p>Importantly, the results presented in <xref ref-type="fig" rid="fig5">Figure 5</xref> contrast with the phenotype of human Hoil-1 deficiency. For instance, one of the Hoil-1 deficient patients described in PMID 23104095 had recurrent cytomegalovirus (human herpesvirus 5) viremia, and even died of complications of cytomegalovirus infection. Other patients had documented herpesvirus infections by VZV, and “viral infections, such as roseola and chicken-pox, followed a regular course and triggered a less prolonged inflammatory response than the pyogenic bacterial infections”. It is also likely that Hoil-1 deficient human patients had additional chronic herpes viral infections, given that EBV, HHV6 and 7 are acquired within the first two years of life for most individuals. Despite these chronic herpes viral infections, they suffer from severe and recurrent bacterial infection. Thus, the results reported in the mouse model, while interesting, do not appear to be broadly applicable to human disease. Likewise, it is not clear why wildtype mice, become susceptible to <italic>listeria</italic> challenge after MHV68 infection, and to a lesser extent, upon infection by MHVorf73.stop (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><p>Overall, the manuscript is interesting and worthy of publication, and we commend the authors on a large body of work that was overall well-done. However, for the reasons described above, this paper may be more appropriate for another journal.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.04494.024</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>We herein respond to comments and queries about our paper ‘Complementation of genetic immunodeficiency by chronic herpesvirus infection’. We believe that we have responded to all of the comments and that this has improved the manuscript.</p><p>Importantly, several new pieces of data have been added to address reviewer questions and potential mechanisms, including data showing that peritoneal macrophages from latently infected <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice have an enhanced ability to kill <italic>Listeria</italic> compared to macrophages from non-latently infected mice and that MHV68 latency rescues, in addition to IL-6 and Hoil-1 deficiency, Caspase1- and Caspase1/Caspase11-deficient mice from <italic>Listeria</italic>-induced lethality. Additionally we confirmed published findings that IL-6-deficient mice are more susceptible to <italic>Listeria</italic> infection than control mice, and extended our findings by showing that control and <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice that have been infected with MHV68 for six months are still partially protected from <italic>Listeria</italic> infection.</p><p><italic>This paper presents a substantial body of work characterizing the responses to infection of mutant mice with HOIL1 deficiency. We were impressed with the extent of the work. As noted by the reviewers, the selectivity of the effects for some pathogens over others is of interest; and most important is the effect of preinfection with MHV68 on subsequent challenges by other pathogens. We summarize some of the key points of criticism here, before passing on the full detailed comments of the reviewers</italic>.</p><p>We thank the reviewers for their helpful comments and criticisms, and hope that the result is a substantially improved manuscript. The majority of the changes have been made to the text to improve readability and to clarify interpretation of the data. Some new experimental data has been added to address specific issues.</p><p><italic>The first reviewer found the paper difficult to read. I too found it very dense and not as linear in presentation as I thought was possible</italic>.</p><p>The paper has been edited to include more description of the rationale for specific experiments as well as more description of the data and interpretation of the results.</p><p><italic>The experiments cover diverse situations and the responses depend on diverse cytokine levels that are introduced as the experiments are described; perhaps some overview of the plan would be helpful to have at the start of the results</italic>.</p><p>We have clarified the summary of our approach and findings at the end of the Introduction section.</p><p><italic>And similarly a clearer summary of the authors' thinking on the cytokines' levels' roles in the outcome would be helpful</italic>.</p><p>More discussion of possible mechanisms and the role of cytokines have been added to the Discussion section.</p><p><italic>In addition, he raises a substantial number of very specific issues that I think need to be addressed. Most cannot be dismissed simply, including issues of significance of some of the findings</italic>.</p><p><italic>The second reviewer had two major issues. The first concerns the effects of MHV68 preinfection in a non-barrier mouse. This is raised because the human situation is obviously non-barrier, and human data might be available to provide information in this setting. While the requested human data would be helpful to have, I am less concerned here about the need to perfectly model the human situation, and comfortable that the barrier mouse findings stand as interesting even without that bearing on the human situation</italic>.</p><p><italic>His second concern is an apparent discrepancy between the data and the claims (this is referring to data in</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5</italic></xref><italic>). This should be directly addressed and clarified</italic>.</p><p>We have addressed this concern as discussed below.</p><p><italic>The third reviewer was also supportive but felt many of the findings were unsurprising or predicted by previous work. I feel that there is adequate value to presenting data that might have been expected but in fact have not previously been obtained (as he notes, surprisingly so!). He also felt that there was insufficient explanation of mechanism of action. I think helpful here, as noted above, is for the authors to at least present a clearer case of what they think is the mechanism, even if the case is not proven. With the right caveats, this would make the paper's punchline much stronger, or at least clearer</italic>.</p><p>We have added a discussion of potential mechanism to the Discussion section and have added a new piece of data that addresses one aspect of potential mechanism. These new data show that, even though cultured Hoil-1 deficient bone marrow-derived macrophages primed with IFNγ are able to kill <italic>Listeria</italic> as effectively as wild-type cells, peritoneal macrophages from <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice showed a reduced capacity to kill <italic>Listeria</italic> (new <xref ref-type="fig" rid="fig5s2">Figure 5–figure supplement 2</xref>). In the setting of latent herpesvirus infection, this deficiency in <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice is corrected to a level commensurate with that observed in control mice that are not infected with the herpesvirus. Therefore the chronic herpesvirus infection provides the capacity for macrophages to control infection in vivo better than they would otherwise be able to do. We also now show that Caspase1-deficient and Caspase1/Caspase11-double-deficient mice, which others have reported to have increased susceptibility to <italic>Listeria</italic> infection, are protected by MHV68 latency. These data have been added to <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p><p>Reviewer #1:</p><p><italic>This is an interesting study that examines the effect of HOIL1 deficiency on infection of mice with several strains of bacteria (</italic>Listeria monocytogenes, Citrobacter rodentium, <italic>and</italic> Mycobacterium Tuberculosis<italic>) a parasite (</italic>Toxoplasma gondii<italic>) and a herpesvirus that establishes a latent infection (murine gamma-herpesvirus 68-MHV68). The results show that the HOIL1 mutant mice are much more susceptible to infection with</italic> Listeria monocytogenes<italic>,</italic> Citrobacter rodentium<italic>, and</italic> Toxoplasma gondii <italic>than wild type mice, but have comparable susceptibility to</italic> Mycobacterium Tuberculosis <italic>and MHV68. Moreover, prior infection of HOIL1 mutant mice with MHV68 reduces their susceptibility to</italic> Listeria <italic>such that it is now comparable to wild type. Latent infection of IL6 mutant mice with MHV68 also reduces their susceptibility to</italic> Listeria <italic>infection.</italic></p><p><italic>The importance of this paper is that it highlights the increasing appreciation that prior viral infection (or bacterial infections) may greatly influence the outcome of subsequent infections and establishment of a hyperinflammatory environment, particularly in the context of immunodeficiency</italic>.</p><p><italic>This is a difficult paper to read, as the differential experimental conditions are not clearly delineated in the text. For example, the measurement of cytokine proteins in serum is interspersed with measurement of transcripts, and it is not always evident in the text what is being measured. Likewise, some infections are in vivo, while others are in bone-marrow-derived macrophages. There is also use of</italic> Rag<sup>-/-</sup> <italic>mice as the background for HOIL1 mutation interspersed with use of the wild type background.</italic></p><p>We have expanded the rationale for the experiments and provided more description of the data presented and interpretation of the results.</p><p><italic>The major criticism is that, mechanistically, it is not clear why the HOIL1 animals are more susceptible to some infections but not others. The assumption is that it is relative level of induced cytokines, but this is never directly shown</italic>.</p><p>We do not know why the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice are less susceptible to MHV68 and <italic>Mtb</italic>. We speculate that it is because the <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice produce an enhanced inflammatory response to these infections including cytokines such as IFNγ that are known to play a role in controlling these infections. However, we are not able to experimentally demonstrate this since deletion of this cytokine and its receptors prevents establishment of quiescent latent infection with either organism, thereby complicating interpretation of studies as to how latent infection might alter host responses to a second infection. Some speculation as to potential mechanisms and relevant references have been added to the Discussion section.</p><p><italic>Although it is stated that the</italic> Mycobacterium Tuberculosis <italic>and MHV68 infections established a hyper-inflammatory phenotype in HOIL1 mutant animals with significant induction of TNFα, IL6, IL12p40, and IFNγ, there is also significant induction of the inflammatory cytokines in wild type mice, albeit to a lower level. Increased expression of inflammatory cytokines is also observed in</italic> Listeria <italic>infected HOIL1 mutant mice, although in this case the levels are lower than those in wild type mice. It is important to note that in some cases the data may be statistically significant, but the differences are marginal.</italic></p><p>The Results section has been expanded with increased description and discussion of the data.</p><p>Specific comments:</p><p><italic>1)</italic> <xref ref-type="fig" rid="fig2s2"><italic>Figure 2–figure supplement 2</italic></xref> <italic>shows that immunized HOIL1 mutant mice are resistant to high dose secondary of</italic> Listeria<italic>. The data are only shown for day 3. Is this resistance maintained at the same level at later times?</italic></p><p>This is an interesting question, and one that we have also pondered. However, the experiment is technically challenging, since 1000 CFU administered i.p. is a border-line dose for inducing protective immunity (you can see in the figure that some of the mice of both WT and mutant genotypes were not well protected), but around 50% of the Hoil-1-mutant mice die from this dose during acute infection (see <xref ref-type="fig" rid="fig1">Figure 1A</xref>). It may be possible to immunize with an attenuated strain (e.g. ActA-deficient), but this will require a significant amount of optimization to determine the required immunization dose (that does not kill the knock-out mice) and a suitable challenge dose with the wild-type <italic>Listeria</italic> strain. Since this a relatively minor point in the paper that addresses the adaptive immune response in <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> animals, whereas the rest of the paper focuses on the role of Hoil-1 in innate immunity, we feel that these experiments are properly beyond the scope of this particular manuscript. We estimate that it would take in the range of 3-4 months, and considerable expense, to work out the appropriate conditions and perform biological replicates to generate data suitable for publication.</p><p><italic>2) It is important in the text to differentiate between small, and likely insignificant differences, versus larger ones. For example, in</italic> <xref ref-type="fig" rid="fig3"><italic>Figure 3</italic></xref><italic>: production of TNFα by HOIL1 mutant mice macrophages is only 2-fold lower than wild type mice infected with</italic> Listeria <italic>while there are greater differences in production of IL-6 and IL12p40.</italic></p><p>The text has been edited accordingly.</p><p><italic>3)</italic> <xref ref-type="fig" rid="fig3s1"><italic>Figure 3–figure supplement 1</italic></xref><italic>: what is the point of this figure? It appears that application of IFNγ has same effect on macrophages in both wild type and HOIL1 mutant, as the wild type do not kill</italic> Listeria <italic>in the absence of IFNγ.</italic></p><p>We failed to make clear the reason that these data are important and have clarified this in the text. Defective IFNγ-induced killing of bacteria could have explained why <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice are more susceptible to <italic>Listeria</italic>, and these data indicate that this is not the case for cultured macrophages.</p><p><italic>4)</italic> <xref ref-type="fig" rid="fig3s2"><italic>Figure 3–figure supplement 2</italic></xref><italic>: it should be stated in text that there is no difference in IL12p40. Also the text should state clearly why the</italic> Rag<sup>-/-</sup> <italic>mouse background is used in</italic> <xref ref-type="fig" rid="fig3s2"><italic>Figure 3–figure supplement 2</italic></xref> <italic>and</italic> <xref ref-type="fig" rid="fig2"><italic>Figure 2B</italic></xref><italic>.</italic></p><p>More rationale, description and discussion of the data has been added.</p><p><italic>5)</italic> <xref ref-type="fig" rid="fig3s3"><italic>Figure 3–figure supplement 3</italic></xref> <italic>only shows data for</italic> Rag<sup>+/+</sup> <italic>mice. Since the</italic> Rag<sup>-/-</sup> <italic>mice are also used, the data for non B and non T cells (e.g. macrophages, neutrophils and NK cells) should also be shown for the HOIL1 mutant mice on this background.</italic></p><p>The flow cytometry data for the <italic>Rag</italic><sup><italic>+/+</italic></sup> mice and the cytokine transcript data for the <italic>Rag</italic><sup><italic>-/-</italic></sup> mice are controls that were included as supplemental information to strengthen and aid in interpreting the data shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. We do not believe that adding information about the dynamics of peritoneal cells in <italic>Rag</italic><sup><italic>-/-</italic></sup> animals will add significantly to the overall conclusions or main points of the paper. We therefore defer to the Editor to determine whether addition of these data is necessary. For analysis of cells at 0, 6 and 12 hours post-infection, approximately 20 mice of each genotype will be required. Since these mice are bred <italic>Rag</italic><sup><italic>-/-</italic></sup><italic>Hoil</italic><sup><italic>+/-</italic></sup> x <italic>Rag</italic><sup><italic>-/-</italic></sup><italic>Hoil</italic><sup><italic>+/-</italic></sup> to generate WT and KO littermates and our current colony produces around 30 total pups per month, with 7-8 being WT and KO mice, we estimate that it will take 3-4 months and considerable expense to generate these data.</p><p><italic>6)</italic> <xref ref-type="fig" rid="fig3"><italic>Figure 3C</italic></xref><italic>: it should be noted that the IL12p40 difference is only seen at one time point</italic>.</p><p>The text has been edited accordingly.</p><p><italic>7) In the Results section, it is stated that fewer NK cells and neutrophils at 6 hours correlated with decreased expression of cytokine and IFNγ mRNA. However, there is no difference in the number of NK and neutrophils at 12 h and differences in cytokine and IFNγ mRNA are still present</italic>.</p><p>We agree and have altered the statement accordingly.</p><p><italic>8)</italic> <xref ref-type="fig" rid="fig4"><italic>Figure 4</italic></xref><italic>: the impairment of reactivation of MHV68 is quite modest (∼2- fold) and it is not “very significant”, as stated in the Results section</italic>.</p><p>The viral reactivation defect, which was shown in panel B (now panel A), is closer to 50-fold. The LD-PCR, which does show about a 2-fold difference in the number of genome-positive cells as a measure of establishment of latency, has been moved into a supplemental to avoid confusion.</p><p><italic>Also the “enhanced control of MHV68 replication” in the HOIL1 mutant mice as measured by lower titers is only seen at two of the time points (</italic><xref ref-type="fig" rid="fig4s1"><italic>Figure 4–figure supplement 1</italic></xref><italic>)</italic>.</p><p>It is stated in the text that “MHV68 replication… was suppressed slightly in vivo”, which refers to the lower titers only seen at two of the time points, and that “<italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice are fully able to control, and may have an enhanced ability to control, specific aspects of acute and chronic MHV68 and <italic>M. tuberculosis</italic> infection”, which we believe to be accurate.</p><p><italic>9)</italic> <xref ref-type="fig" rid="fig4"><italic>Figure 4C</italic></xref><italic>: given MHV68 infected wt mouse outlier, the data do not appear to be significant for TNFα.</italic></p><p>While it is possible that the outlier is due to experimental error, we are unwilling to remove the data point without a clear rationale for doing so. The statistical significance is not lost by removing this point. The text has been edited to accurately reflect the small fold change.</p><p><italic>10) The legend for</italic> <xref ref-type="fig" rid="fig4"><italic>Figure 4E</italic></xref> <italic>is incorrect. It states that it is the same as 4D. However, from the text in the Results section, this appears to show the data for the mice infected with tuberculosis. What day of the infection is shown</italic>?</p><p>Thank you for picking up this typing error. It should have said 4C (now 4B) and has been modified. The time point is day 70, and this information is given in the legend and has been added to the main text for clarity.</p><p><italic>11)</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5</italic></xref><italic>: it should be clearly stated in the text that the MHV68 latency provided enhanced resistance to</italic> Listeria <italic>infection not only for the HOIL1 mutant and IL6 mutant mice, but also for the wild type mice. Also, from the data shown, one cannot state that the IL6 mutant mice had increased sensitivity to</italic> Listeria <italic>infection, as both the mutant and wild type mice showed the same survival curve due to the large inoculum of</italic> Listeria <italic>that is used.</italic></p><p>More description of the data has been included. The data showing that <italic>IL-6</italic><sup><italic>-/-</italic></sup> mice have increased sensitivity to <italic>Listeria</italic> has been published by another group and the reference is provided. However, since this is an important point in the paper and only one reference exists, we have now confirmed that <italic>IL-6</italic><sup><italic>-/-</italic></sup> mice are more susceptible to <italic>Listeria</italic> infection. These data are now provided in <xref ref-type="fig" rid="fig5s3">Figure 5–figure supplement 3</xref>.</p><p>Reviewer #2:</p><p><italic>1) The authors show that infection with MHV68 strengthens the immune response of the</italic> Hoil-1<sup>-/-</sup> <italic>mice to subsequent infection with other pathogens. It is essential to know what happens to non-barrier-raised subjects as human patients with Hoil-1 deficiencies are continuously exposed to pathogens. In this context the authors could, for example, look at the high-throughput sequencing data available for human Hoil-1 patients and determine if there are correlations between clinical symptoms and presence/absence of specific pathogens in those samples.</italic></p><p>We certainly would like to know the infection status of the HOIL-1 patients with various phenotypes. However, to our knowledge, high-throughput sequencing data or complete serologic data is not available for reported HOIL patients, and we have been unsuccessful in obtaining samples from the two groups that reported HOIL-1 patients with cardiomyopathy but without immunodeficiency. We hypothesize that the humans do not show quite such a striking immunodeficiency when compared to the SPF mice due to their constant exposure to pathogens, and hence latent infection of SPF mice with MHV68 may allow the mouse phenotype to more closely mimic the human phenotype. Notably patients reported to be immunodeficient also received immunosuppressive drugs to treat their auto-inflammation. We agree that the relevance of the present study to humans remains to be proven, and we have added a similar statement to the Discussion.</p><p><italic>2) There exists a dissonance in the authors' proposal as to how infection with MHV68 or</italic> M. tuberculosis <italic>protects the</italic> Hoil-1<sup>-/-</sup> <italic>mice from subsequent pathogen challenges. While in the Discussion section the authors write “MHV68 latency was associated with increased basal levels of TNFα, IL-6, IL-12 and IFNγ…”,</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5C</italic></xref> <italic>indicates that TNFα, IL-6 and IL-12 levels did not rise with MHV68 infection. The authors need both to address this discrepancy and explain how IFNγ levels are increasing in the</italic> Hoil-1<sup>-/-</sup> <italic>mice when they are infected with MHV68.</italic></p><p>We appreciate that <xref ref-type="fig" rid="fig5">Figure 5C</xref> was difficult to interpret. We have added color, increased the size of the panels and split the data from T=0 and T=3 hours after <italic>Listeria</italic> infection into separate panels to help with visualization. Both <xref ref-type="fig" rid="fig4">Figure 4D</xref> (now 4C) and <xref ref-type="fig" rid="fig5">Figure 5C</xref> show that MHV68 latency is associated with increases in these cytokines in the serum and in peritoneal cells for both control and <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice (although IL-12 transcripts were not significantly elevated in WT mice compared to naïve mice). Significant findings are indicated above the symbols. We do not know why IFNγ levels are increased in <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice compared to controls when they are infected with MHV68. We have speculated as to the mechanisms in the Discussion.</p><p>Reviewer #3:</p><p><italic>MacDuff and colleagues use a</italic> Hoil-1<sup>-/-</sup> <italic>mouse model to examine the role of Hoil-1 in host-defense against bacterial, parasitic, and viral infections. Although the Hoil-1 knockout has been available since 2009, surprisingly, it has not yet been characterized with infection models in detail. By comparison, biallelic loss-of-expression and loss-of-function HOIL-1L deficiencies in humans causes a fatal disorder characterized by chronic auto-inflammation, invasive bacterial infections, and muscular amylopectinosis. Likewise, mice deficient in the LUBAC component sharpin have immune-deficiency.</italic></p><p>We have added a summary of the phenotypes of the Sharpin mutant mice to the Introduction and a comparison with the Hoil-1-deficient mice to the Results. Sharpin mutant mice have disorganized lymphoid organs that has been described as immunodeficiency, whereas <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice do not.</p><p><italic>MacDuff et al. report that in barrier-housed mice, amylopectin-like deposits occur, but hyper-inflammation does not. Nonetheless, they are immunodeficient, and are highly susceptible to challenge with</italic> listeria, toxoplasma or citrobacter<italic>.</italic></p><p><italic>The authors show that Hoil-1 expression in bone-marrow-derived cells is important for protection from bacterial challenge, and for cytokine production.</italic> Hoil-1<sup>-/-</sup> <italic>mice survive at least 3 months of challenge with γ-68 herpesvirus (IP or intranasal), with similar levels of intraperitoneal pool of latent virus. By contrast, they observed that MHV68 reactivation from latently-infected peritoneal cells was impaired by</italic> Hoil-1<sup>-/-</sup> <italic>deficiency. Challenge with wildtype MHV68 or</italic> mycobacterium tuberculosis <italic>leads to enhanced production of IL-6, IL-12 and IFNγ in Hoil-1 deficient mice, and also higher levels of TNFα in MTB- treated Hoil-1 deficient mice. Mice infected with MHV68 for 28 days are protected from IP challenge with</italic> listeria<italic>, while MHV68orf73.stop, which does not establish latency, does not protect Hoil-1 knockout mice from</italic> listeria <italic>challenge.</italic></p><p><italic>A strength of the manuscript is that it raises many interesting issues, and highlights the role of LUBAC and inflammation in the host-response to infection. However, many of the results presented are incremental advances that are largely expected from the current literature. For instance, based on the phenotype of humans with Hoil-1 deficiency, it is not surprising that mice are highly susceptible to bacterial challenge (</italic><xref ref-type="fig" rid="fig1"><italic>Figure 1</italic></xref><italic>). Likewise, although it is interesting that Hoil-1 expression in hematopoietic cells and even in the granulocyte lineage is important for control of</italic> listeria<italic>, it is not a particularly surprising result (</italic><xref ref-type="fig" rid="fig2"><italic>Figure 2</italic></xref><italic>). That cytokine production is impaired in Hoil-1 knockouts in response to</italic> listeria <italic>is also a largely expected result (</italic><xref ref-type="fig" rid="fig3"><italic>Figure 3</italic></xref><italic>).</italic></p><p>Of the 16 Hoil-1 mutant patients reported to date, only three were reported to be immunodeficient, calling into question whether Hoil-1 deficiency results in immune-deficiency. This is now mentioned in the Introduction and Discussion. While it is true that decreased cytokine production is the expected result, a recent study by Rodgers MA et al., J Exp Med, 2014 found that Hoil-1 is not required for NFκB activation or NFκB-dependent gene expression in bone marrow derived macrophages following LPS or TNF α treatment. Our data show that Hoil-1 is required for efficient cytokine production by bone marrow derived macrophages following <italic>Listeria</italic> infection, suggesting that Hoil-1 is required for proper activation of NFκB in response to certain stimuli in these cells.</p><p><italic>It is however interesting that Hoil-1 deficiency has protective effects on MHV68 infection and tuberculosis. While we are shown modest decreases in MTB loads in lung and spleen in Hoil knockouts, we are not shown whether MHV68 viral load is affected by Hoil-1 deficiency, but rather that similar levels of latently infected cells are present in the peritoneum, that MHV68 reactivates less efficiently with Hoil-1 deficiency, and that MHV68 results in increased pro-inflammatory cytokine production with hoil deficiency (</italic><xref ref-type="fig" rid="fig4"><italic>Figure 4</italic></xref><italic>)</italic>.</p><p><italic>Perhaps because of this cytokine production that exists 28 days after viral inoculation, Hoil-1 mice are protected from listeriosis</italic>.</p><p>MHV68 viral load is minimally decreased in the absence of Hoil-1 as shown in <xref ref-type="fig" rid="fig4">Figure 4</xref> and figure supplement 1B. We agree that it is likely that the increased cytokine production during MHV68 latency protects the mice from listeriosis. We have included more discussion of possible mechanism in the Discussion section.</p><p><italic>While the results are interesting, a shortcoming of the paper is the lack of novel mechanistic insights. What is the intrinsic mechanism of how latent infection with γ68 protects mice from subsequent challenge with</italic> listeria<italic>? Is it a phenomenon that exists during acute herpesvirus infections?</italic></p><p>Barton et al., Nature, 2007 showed that acute infection (after 1 week) does not confer protection against <italic>listeria</italic> in wild-type mice, and that a virus that can undergo acute replication, but does not establish latency effectively (MHV68 orf73.stop), also does not protect against <italic>listeria</italic> infection after 4 weeks. We have included data from experiments using the orf73.stop mutant virus in both wild-type and mutant mice (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), which indicate that immune stimulation from the acute phase of infection is not responsible for the protection. However, we have not challenged <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice with <italic>Listeria</italic> during acute MHV68 infection. It is possible that the outcome would be different to that for wild-type mice.</p><p>As suggested by the Editor, we have included more discussion of possible mechanisms. It appears that MHV68 latency increases the basal activation state of the innate immune system, perhaps priming it to respond more rapidly to subsequent infections that also induce IFNγ and IFNγ-dependent effector mechanisms. For example, macrophages require IFNγ to make IL-12 in response to <italic>Listeria</italic> infection. In a latently infected animal, IFNγ is already present and so IL-12 is induced much more rapidly and IFNγ is further up regulated faster than in a non-latently infected animal.</p><p>A new piece of data that addresses one aspect of potential mechanism has also been added. Even though Hoil-1 deficient bone marrow-derived macrophages primed with IFNγ are able to kill <italic>Listeria</italic> as effectively as wild-type cells (shown in <xref ref-type="fig" rid="fig3s1">Figure 3–figure supplement 1</xref>), peritoneal macrophages from <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice showed a reduced capacity to kill <italic>Listeria</italic> (new <xref ref-type="fig" rid="fig5s2">Figure 5–figure supplement 2</xref>). As has been shown previously (Barton et al., Nature, 2007), peritoneal macrophages from latently-infected wild-type mice have an enhanced ability to kill <italic>Listeria</italic>. Peritoneal macrophages from latently infected <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice also showed an enhanced ability to kill <italic>Listeria</italic> when compared to cells from wild-type or <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice that are not latently infected. However, these cells do not kill <italic>Listeria</italic> as effectively as cells from latently infected wild-type mice. We speculate that the difference in listericidal activity of bone marrow-derived macrophages and peritoneal macrophages may reflect differences in the environment in the peritoneum of wild-type and mutant mice.</p><p><italic>By analogy with human infectious mononucleosis, MHV68-infected mice are likely immune-stimulated by acute herpes virus infections at 28 days post-infection. Does protection from listeriosis persist at later timepoints following MHV68 infection (the situation in most humans with asymptomatic/chronic herpes virus infections), or is it merely a transient phenomenon of acute infection? Since Hoil-1 knockout mice survive for at least 3 months after MHV68 infection, repeating the experiments at that timepoint would add something to the study</italic>.</p><p>Both control and <italic>Hoil-1</italic><sup><italic>-/-</italic></sup> mice are still partially protected from <italic>listeria</italic> infection 6 months after MHV68 infection, and these data are now in <xref ref-type="fig" rid="fig5s1">Figure 5–figure supplement 1</xref>.</p><p><italic>Importantly, the results presented in</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5</italic></xref> <italic>contrast with the phenotype of human Hoil-1 deficiency. For instance, one of the Hoil-1 deficient patients described in PMID 23104095 had recurrent cytomegalovirus (human herpesvirus 5) viremia, and even died of complications of cytomegalovirus infection. Other patients had documented herpesvirus infections by VZV, and “viral infections, such as roseola and chicken-pox, followed a regular course and triggered a less prolonged inflammatory response than the pyogenic bacterial infections”</italic>.</p><p>We agree that this is an apparent difference, but MHV-68 is a γ-herpesvirus and HHV5 is a β-herpesvirus and the pathogenesis of the viruses may be quite distinct therefore. We have not challenged our mutant mice with a β-herpesvirus.</p><p><italic>It is also likely that Hoil-1 deficient human patients had additional chronic herpes viral infections, given that EBV, HHV6 and 7 are acquired within the first two years of life for most individuals. Despite these chronic herpes viral infections, they suffer from severe and recurrent bacterial infection. Thus, the results reported in the mouse model, while interesting, do not appear to be broadly applicable to human disease. Likewise, it is not clear why wildtype mice, become susceptible to</italic> listeria <italic>challenge after MHV68 infection, and to a lesser extent, upon infection by MHVorf73.stop (</italic><xref ref-type="fig" rid="fig5"><italic>Figure 5B</italic></xref><italic>).</italic></p><p>We agree that it is possible that HOIL-1 mutant patients were infected with multiple herpesviruses, but have been unable to obtain samples with which to test this. The immunodeficiencies in the human patients were actually relatively mild, particularly given that they were on steroid treatments to suppress the auto-inflammation. The SFP mice appear to have a much more severe immunodeficiency than the humans, which is made less severe by MHV68 latency. We agree that it is difficult to directly compare humans with SPF mice. We used a γ-herpesvirus model for our mouse studies, but α-(i.e. VZV) or β-(i.e. HCMV)-herpesviruses may not produce the same phenotypes.</p></body></sub-article></article>